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2 ZUSAMMENFASSUNG (Deutsch) 
Zur Aufrechterhaltung der Homöostase und der Regeneration von Geweben und Organen 
existieren im Säugetierorganismus verschiedene residente adulten Stammzellen. Der 
Herzmuskel besitzt nur eine geringe Selbstheilungsfähigkeit, welche durch lokale adulte 
Stammzellen ermöglicht wird. Diese sind in der Lage, glatte Muskelzellen, Endothelzellen 
oder auch beschädigte Kardiomyozyten zu ersetzen. Die Herkunft und die Identität dieser 
kardialen adulten Stammzellen sind nicht eindeutig definiert. In diese Arbeit ein genetisches 
Zellmarkierungssystem verwendet, das gezielt Sca1-exprimierende Zellen markiert und damit 
eine in vivo Verfolgung der genetischen Abstammung dieser Zellen ermöglicht. Sca1 ist einer 
der am häufigsten verwendeten adulten Stammzellmarker. Die Analyse der markierten Zellen 
im Herzen ergab, dass sowohl im Alterungsprozess als auch unter pathologischen 
Bedingungen die von Sca1-abstämmenden Zellen zu den drei wesentlichen kardialen 
Zelllinien differenzieren. Dies deutet auf eine Rolle von Sca1-exprimierenden Zellen bei der 
kardialen Selbsterneuerung hin. Sowohl in vivo als auch Transkriptomdaten zeigten, dass 
diese eine heterologe Zellpopulation bilden und eine spezifische Lokalisation im Herzen 
besitzen. Die Skelettmuskulatur besitzt hingegen ein hohes regeneratives Potential. 
Ermöglicht wird dies durch adulte Vorläuferzellen, die Satellitenzellen, welche zu 
Skelettmuskelfasern differenzieren können. Obwohl Satellitenzellen als grundlegende 
Stammzellquelle im Skelettmuskel gelten, wurden in den letzten Jahren alternative Quellen 
von multipotenten Zellpopulationen, die Sca1 exprimieren, beschrieben. Mit Hilfe des in vivo 
Zellmarkierungsmodells konnten wir zeigen, dass Sca1-exprimierende Zellen an der 
Muskelregeneration, wenn auch in wesentlich geringerem Maße als Satellitenzellen, beteiligt 
sind. Darüber hinaus konnte nachgewiesen werden, dass eine kleine Population Sca1-
exprimierender Zellen unabhängig von Pax7, in Muskelfasern differenzieren kann. 
Desweiteren wurde die Plastizität von Satellitezellen und Sca1- exprimierenden Zellen in vivo 
untersucht und durch Genexpressionanalysen bestätigt. Diese Daten belegten, dass 
Satellitenzellen eine unipotente Stammzellpopulation darstellen, die nur Muskelfasern 
regenerieren können. Dagegen zeigten sich Sca1-exprimierenden Zellen multipotent und 
waren in der Lage zu Adipozyten oder Osteoblasten zu differenzieren. Somit konnte ich 
darlegen, dass Sca1-exprimierende Zellen in der Lage sind, zu Regeneration von Myozyten 
beizutragen. Eine weitere Charakterisierung dieser Sca1-exprimierende Zellen wird wichtige 
Erkenntnisse über den molekularen Mechanismus, welcher Herz- und Muskelstammzellen im 
Menschen reguliert, liefern. Diese Erkenntnisse könnten hilfreich sein, um mögliche 
therapeutische Behandlungen für Herz- und Skelettmuskelerkrankungen zu entwickeln.
ABSTRACT 
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3 ABSTRACT (English) 
Different types of resident adult stem cells exist in mammalian organs in order to maintain 
tissue homeostasis and organ repair.  
Even though the heart has low regenerative capacity it has been demonstrated that resident 
adult stem cells exist and are able to replace smooth muscle cells, endothelial cells and 
damaged or lost cardiomyocytes. Currently, the origin and the identity of cardiac resident 
adult stem cells remain controversial. In this study, descendants of cells that have expressed 
Sca1, which is one of the most widely used adult stem cell markers, were traced. Their 
contribution to self-renewal in the heart during aging and under pathological conditions was 
characterized. In both conditions, Sca1-expressing cells could differentiate into three major 
cardiac lineages, providing evidence of their role in myocardial renewal. These cells appeared 
to be a heterogeneous population in vivo as well as at a transcriptomic level, showing a 
specific location in the heart.  
Unlike the heart, skeletal muscle shows a high regenerative potential. It contains adult 
resident progenitor cells called “satellite cells”, which are able to differentiate into mature 
muscle fibers. Although satellite cells are considered to be the principal stem cells in the 
skeletal compartment, recent works have identified alternative sources of multipotent stem 
cells that are positive for Sca1. In this study, an in vivo lineage tracing approach in skeletal 
muscle revealed that Sca1-expressing cells are involved in skeletal muscle regeneration, 
although their contribution is lower compared to satellite cells. It was also possible to identify 
a small population of Sca1-expressing cells able to differentiate into muscle fibers without 
expressing Pax7, a marker for satellite cells known to be involved in quiescence, proliferation 
and differentiation of myogenic cells. Furthermore, the plasticity of satellite cells and Sca1-
expressing cells was tested in vivo and was confirmed by gene expression profiling analysis. 
The data obtained verified that satellite cells are unipotent stem cells only able to regenerate 
skeletal muscle fibers. In contrast to satellite cells, Sca1-expressing cells are revealed to be 
multipotent and have the ability to differentiate into adipocytes and osteoblasts. 
In conclusion, this study confirmed the presence of Sca1-expressing cells that are able to 
contribute to myocyte regeneration in the heart and skeletal muscle. Further characterization 
of these Sca1-expressing cells will provide valuable insights into the molecular mechanisms 
regulating cardiac and muscle stem cells in humans. Importantly, this could aid the future 
development of therapeutic strategies for human cardiac and skeletal muscle diseases.
   INTRODUCTION 
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4 INTRODUCTION 
4.1 Stem cells 
In the last few decades, the idea of using embryonic and/or adult stem cells to treat 
degenerative diseases (e.g. Parkinson´s disease, Alzheimer´s disease, multiple sclerosis, 
muscle skeletal dystrophy) has gained momentum with the hope of improving the health and 
quality of life of many of these patients. Although the concept of stem cells has existed for 
more than a century, the current hype surrounding stem cells, both in the scientific and public 
community has undoubtedly arisen due to many recent major scientific discoveries and 
developments in this field.  
Stem cells can be defined as primordial cells, which are able to divide and differentiate into 
other cell lineages in an organism as well as being able to maintain a pool of undifferentiated 
cells. By definition, the major properties defining the stemness of a cell are: 
1. Self-renewal. The ability of a cell to renew through numerous and unlimited cell cycle 
divisions, while keeping an undifferentiated state. To do this a stem cell divides in two 
ways (Figure 1):  
- Symmetric division: a mother cell gives rise to two identical daughter cells 
that maintain the stemnness. 
- Asymmetric division: from the same cell, two types of daughter cells arise, 
where one keeps the stemness and another (called “progenitor cell”) is able to 
terminally differentiate into distinct cell types. 
                                  
 
Figure 1. Symmetric and asymmetric cell division.  
A: stem cell; B: progenitor cell; C: differentiated cell. (1) A stem cell 
can divide symmetrically into two identical daughter stem cells (called 
“symmetric division”). (2) Through asymmetric division, one stem cell 
gives rise to another stem cell and one progenitor cell. (3). Then, the 
progenitor cell divides into two daughter cells. (4) These daughter cells 
differentiate into mature cell types1. 
   INTRODUCTION 
7 
2. Potency: defined as the capacity of a cell to differentiate into other lineages. As shown 
in Figure 2, potency is further defined as either: 
- Totipotent (e.g. morula cells): these stem cells are produced from the fusion of 
oocytes with sperm or are derived from the early divisions of the fertilized 
oocyte. They can differentiate into all the embryonic and extra-embryonic 
cells, including placenta. 
- Pluripotent: this type of stem cell includes embryonic stem cells from the inner 
cell mass of the blastocyst, which can differentiate into the cells of all three 
germ layers (ectoderm, endoderm and mesoderm). However, these pluripotent 
cells cannot contribute to the placenta.  
- Multipotent: these stem cells are able to differentiate into specific cell types 
only (e.g. hematopoietic stem cells differentiate into erythrocytes, leucocytes, 
platelets). 
- Unipotent: these cells can only differentiate into one cell type, but they are able 
to self-renew, which distinguishes them from lineage committed cells (e.g. 
neuronal cells, satellite cells). 
      
Stem cells with different potency can be found in an organism throughout life. During 
adulthood, resident stem cells are confined to specific organs and function to ensure the 
maintenance of tissue homeostasis. Based on the time frame and the origin, a stem cell can be 
characterized as embryonic, fetal or adult.  
Figure 2. The potency of stem cells.  
Totipotent cells are derived from fertilized oocyte 
and they are able to differentiate into all 
embryonic and extra-embryonic tissues. The 
pluripotent cells derived from the inner cell mass 
of blastocysts differentiate into all the cell types 
belonging to the three germ layers. Multipotent 
cells differentiate into several cell types, while 
unipotent cells are able to give rise to only one cell 
type but are able of self-renew2. 
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4.1.1 Embryonic stem cells and induced pluripotent stem cells  
Embryonic stem (ES) cells are derived from the epiblast of the inner mass of blastocysts, 
which consists of approximately 50-150 cells at embryonic stage day 4-5 after fertilization, or 
additionally, they are derived from the early embryonic stages of the morula. ES cells are 
pluripotent and are able to differentiate into all the cell types of the three germ layers: 
ectoderm, endoderm, mesoderm (Figure 3). ES cells do not contribute to the extra-embryonic 
membrane and placental formation. They can be identified by the presence of different 
transcription factors such as OCT4 (octamer binding protein 4), SOX2 (SRY, sex determining 
region Y-box 2) and GATA4 (binding the GATA DNA region). ES cells can also be 
characterized by the presence of specific surface markers although they are not universal, but 
rather species related. Human ES cells are positive for SSEA4 (Stage Specific Embryonic 
Antigens), TRA-1-60 and TRA-1-81 (Tumor rejection antigen)3, while mouse ES cells 
present the antigen SSEA1 (Table 1)4. It is possible to cultivate ES cells by growing them on 
feeder cell layers of embryonic fibroblasts (e.g. murine embryonic fibroblasts, MEF) or in a 
conditioned medium that contains leukemia inhibitory factor (LIF), an inhibitor of 
differentiation. ES cells have high levels of telomerase activity5, have a very short G1 cell 
cycle, and initiate DNA replication without external stimulation6. Mouse ES cells are the most 
well-studied, although ES cells have been derived from a number of different species7 
including human blastocysts8. Remarkably, ES cells display unlimited proliferation in vitro 
and an ability to differentiate into all the cell types of an organism. Due to these 
characteristics, ES cells have been extensively studied for their potential application in cell 
therapy in the hope of treating chronic and degenerative diseases (e.g. Parkinson´s disease)9. 
Stem cell therapy is based on injecting or transplanting stem cells into a damaged organ or 
tissue in order to repair the injury or treat the disease. This approach was first carried out in 
196810 when the first bone marrow transplantation was achieved. ES cells, due to their 
multipotency and plasticity represent a perfect source for cell therapy. However, the use of ES 
cells raises ethical problems due to the generation of ES cells from human pre-implantation 
embryos. Furthermore, it often leads to oncogenic and immunogenic problems11. A possible 
solution to prevent the risk of immunological rejection is through the use of genetic 
engineering techniques to induce ES cells to express the hosts´ histocompatibility antigen or 
to produce ES cells that are genetically identical to the recipient of the transplantation12. 
Furthermore, induced pluripotent stem cells (iPS cells)13 represent a possible alternative stem 
cell source compared to ES cells. IPS cells are stem cells obtained from culturing mouse 
embryonic or adult fibroblasts in the presence of four factors (OCT3/4, SOX2, C-MYC, and 
   INTRODUCTION 
9 
KLF4) and these cells present properties similar to ES cells. Recent reports indicate that, 
although iPS cells showed no tumorigenic problems, certain genetic and epigenetic 
abnormalities still occur during their reprogramming and their maintenance in the cell 
culture14. ES and iPS cells are not the only sources of cell stem cells available for therapy. As 
mentioned before, bone marrow cells are most commonly used as well as stem cells from 
umbilical cord derived cells, placenta cells, adipose tissue cells15, satellite cells16, skeletal 
myoblasts16 and resident cardiac stem cells16. To date, various studies have been performed 
using stem cells to treat brain damage17, spinal cord injury18, diabetes19, Parkinson disease20, 
baldness21, blindness22, cardiovascular diseases23 and muscular dystrophies24. 
 
 
Figure 3. Pluripotency of embryonic stem cells3. 
 
 
Table 1. Markers for human and murine ES cells4. 
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4.1.2 Fetal stem cells 
Fetal stem cells are multipotent with characteristics between ES cells and adult cells. In 
particular, fetal stem cells show a phenotype similar to adult stem cells but with a more plastic 
phenotype compared to adult stem cell25. Fetal stem cells are characterized by high telomerase 
activity that allows for a greater replication potential and protects against aging. These cells 
are found in the cord blood, the placenta and the amniotic fluid. Although the umbilical cord 
is known for being the major reservoir of hematopoietic cells, recently, mesenchymal stem 
cells (MSCs) have also been isolated26, which could be considered as fetal stem cells. 
Compared to the umbilical cord, the amniotic fluid and the placenta are easy to obtain. In 
these tissues, different stem cell populations (e.g. mesenchymal stem cells, hematopoietic 
stem cells, trophoblasts) have been found27. In the placenta, cells with high proliferative 
potential28 or with immunomodulation properties that are implicated in fetal tolerance29 have 
been identified. The amniotic fluid contains cells derived from all three germ layers30,31. 
These stem cells include MSCs30,32 and CD117 (C-KIT)-positive subpopulations33. 
 
4.1.3 Adult stem cells 
Adult stem cells are cells present in the adult organism which are able to divide in an 
asymmetric manner to give rise to identical cells and progenitor cells that are able to 
differentiate into alternative, more lineage-committed cell types. These adult stem cells are 
also called “somatic stem cells” (from greek Σωματικóς, belonging to the body) as wells as 
“germ stem cells”. The majority of multipotent adult stem cells are usually defined by the 
name of the tissue they are originating from or associated with (e.g. mesenchymal stem cells, 
endothelial stem cells, etc.). The role of adult stem cells is to generate new cells that are able 
to maintain and repair the damaged tissue. The concept of adult stem cells was first suggested 
in 199034. Researchers identified the presence of two different cell populations in the blood 
that were able to differentiate into a number of distinct cell types. These two populations of 
adult stem cells are: hematopoietic stem cells (forming all types of blood-related cells in the 
body34) and bone marrow stromal cells (generating bone, cartilage, fat, and fibrous connective 
tissue)35. The findings of adult stem cells in various tissues and the possibility of manipulating 
them resulted in increased focus and attention of researchers around the world, which led to 
the creation of a scientific field called “regenerative medicine”. A major goal of regenerative 
medicine is to stimulate and control the capacity of adult stem cells to differentiate into other 
cell types in order to use them as a source for cell therapies to treat serious common diseases.  
   INTRODUCTION 
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4.1.3.1 Resident adult stem cells and the concept of niche 
Through intensive research, it is now evident that resident adult stem cells are present in most 
of the organs in the human body to achieve tissue homeostasis and repair. Furthermore, each 
organ shows a different strategy in self-renewal using resident adult stem cells. Based on such 
strategies, it is possible to define organs with high cellular turnover and regenerative potential 
(e.g. gut, epithelium, epidermis), low cellular turnover but high regenerative potential (e.g. 




Figure 4. Scheme of potential regeneration and cellular turnover of different organs and tissues36. 
 
Hair follicles, blood and gut belong to the first category. These organs and tissues are 
constantly renewing and contain adult stem cells that are morphologically unspecialized. 
These adult stem cells have a low rate of division and are located in specific regions of the 
tissues called “niches”, which regulate the behavior of adult stem cells (e.g. stemness)37. In 
the field of stem cells, the term “niche” first appeared in 1978. However, only after several 
studies reporting the presence of such locations in Drosophila, its concept was accepted by the 
scientific community. The niche is an environment that can control the quiescence and the 
activity of stem cells. It creates a particular surrounding that protects stem cells from external 
stimuli (differentiation stimuli, apoptotic stimuli, etc.) that could challenge their quiescence. 
At the same time, it controls the production of stem cells to avoid the development of cancer 
due to uncontrolled cell proliferation38. Furthermore, within the niche are secreted substances 
that allow stem cells to produce the so-called “transit amplifying (TA) daughter cells”. TA 
daughter cells have a high rate of proliferation, can self-renew over a short term and give rise 
to precursors of all or many of the differentiated cell types of the organ that they are located 
in39 (Figure 5).  




The second group of organs and tissues, characterized by a low cellular turnover but a high 
regenerative potential, can maintain their tissue homeostasis without the need of 
undifferentiated adult stem cells. Instead, these organs and tissues contain so-called 
“facultative” stem cells, which are quiescent differentiated cells that behave like adult stem 
cells, with the potential to replicate themselves to replace the damaged tissues upon injury36.  
In the liver, for instance, upon hepatectomy (the surgical removal of the liver) the turnover 
and regeneration are acquired through hepatocyte differentiation40. In the muscle, 
regeneration is a result of proliferation and subsequent differentiation of resident progenitor 
cells called “satellite cells”41. 
In the third and last group, which shows a low cellular turnover and a low regenerative 
potential, lung, brain and heart are included. These are complex organs with a limited 
endogenous repair capacity following acute injuries; possibly due to the presence of resident 
adult stem cells with a limited potential of tissue repair. 
Below, the two principal muscles present in an organism, cardiac and skeletal muscle will be 
further described together with their possible adult stem cell populations. 
 
4.2 Heart 
The heart is the first organ to become functional during embryonic development. It is 
composed of different cell types. Among them, the following four cell types are the most 
abundant: cardiomyocytes, endothelial cells, vascular smooth muscle cells and fibroblasts. It 
was previously accepted that a great part of the heart is represented by cardiomyocytes. 
Figure 5. An example of classical 
hierarchy of adult stem cells in epithelial 
cells39.  
The model represents how undifferentiated 
epithelial stem cells, transit amplifying (TA) 
cells, progenitor cells and mature post 
mitotic differentiated cells are derived and 
controlled. The stem cell in its “niche” gives 
rise to different subclasses of TA cells, 
which can self-renew more rapidly than 
parental stem cells. (1) Early TA cells can 
replenish a stem cell pool; (2) A direct 
“transdifferentiation” of a differentiated cell 
into another cell type; (3) Dedifferentiation 
of more differentiated cells into more plastic 
TA cells, which creates distinct 
differentiated cells than the original ones; 
(4) Metaplasia or Transdetermination, 
where stem cells switch from one tissue-
specific lineage to another. 
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However, a closer look in the murine heart revealed a proportion of ~56% cardiomyocytes, 
27% fibroblasts, 10% vascular smooth muscle cells and 7% endothelial cells42. In contrast, rat 
and human hearts show a similar composition in which fibroblasts (62.6%) are the major cell 
type42,43. Cardiomyocytes comprise only 26.4% in the rat and 20% in the human heart44. 
Given such similarity between the hearts of rats and humans compared to the mouse heart, 
rats clearly represent a better animal model for the study of cardiovascular diseases. However, 
until now, the difficulty in the genetic manipulation of rats45, restricted the use of this 
experimental animal model. These limits and the possibility of purchasing reliable knockout 
mice favoured the mouse as the principal investigating model. 
Cardiovascular disease (e.g. coronary heart disease, cardiomyopathy, heart failure, etc.) still 
remains one of the major causes of death around the world. This has increased the scientific 
interest in searching for ways to promote regeneration of cardiac tissue after damage. During 
the last century, the heart was considered a post-mitotic organ that is not able to regenerate 
during aging and upon damage. Although remodelling processes occur upon aging or damage, 
it was thought that such processes are due to cardiomyocyte hypertrophy rather than 
cardiomyocytes proliferation46,47. However, recent reports have suggested that the heart is an 
organ that is able to self-renew. In 2007 Hsieh and colleagues reported that upon cardiac 
injuries (i.e. myocardial infarction or pressure overload), cardiomyocyte turnover occurs in 
the murine heart, but not during normal aging48. In 2009, using carbon-14 (C14), Bergmann et 
al. confirmed the evidence of cardiomyocyte renewal in human hearts49. This isotope, 
released in the atmosphere after World War II nuclear bomb testing was absorbed by the 
human body resulting in a labeling of cardiomyocytes. This allowed the research group to 
estimate the age of cardiomyocytes and hence provided a way to measure renewal. According 
to their calculations, at the age of 25 years, approximately 1% of cardiomyocytes turnover 
annually, and the turnover rate decreases to 0.45% at the age of 75 years. Overall, it was 
estimated that approximately 50% of cardiomyocytes are exchanged during a normal life 
span49. However it is still not completely clear, what is the source of this renewal. It has been 
demonstrated that several types of somatic stem cells can contribute to the renewal of the 
heart: BMCs (bone marrow cells), HSCs (hematopoietic stem cells) and MSCs (mesenchymal 
stem cells). Although BMCs and HSCs showed a certain capacity to ameliorate cardiac 
function once injected, it was shown that they are not able to differentiate into 
cardiomyocytes50. MSCs are, indeed, able to contribute to heart regeneration due to their 
cardiomyogenic properties both in vivo51 and in vitro52. Toma et al. proved in vivo that hMSC 
transplanted in mice were able to differentiate into cells, presenting a level of desmin, beta-
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myosin heavy chain, alpha-actinin, cardiac troponin T comparable to those of the host 
cardiomyocytes. Makino et al., on the other hand, demonstrated that murine bone marrow 
stromal cells treated with 5-azacytidine, a hypomethylating agent, acquired in vitro myotube-
like morphology and spontaneously started beating52. Another possible source of such 
renewed cardiomyocytes is the so called “cardiac stem cells” (CSCs)53. 
 
4.2.1 Cardiac stem cells 
Cardiac stem cells (CSCs) (also known as “cardiovascular progenitor cells (CPs)) are resident 
adult stem cells in the heart that are able to give rise to different lineages (e.g. 
cardiomyocytes, endothelial cells, smooth muscle cells, etc.) in vitro and in vivo54.  
Whether these CSCs possess stemness and multipotency is still debatable. Furthermore, due 
to the lack of lineage tracing studies to uncover the origin and role of CSCs, the distinction 
between adult stem cells and progenitor cells in the heart is lacking in the field. To date, 
several molecular markers have been reported to identify CSCs. Based on their different 
profiles, six groups of CSCs can be defined as shown in table 255.The possibility of the 
existence of resident stem cells is favorable from the clinical point of view. A precise 
characterization of this population will be helpful in the future in terms of cell therapies 
because it will allow a higher accuracy regarding cell isolation and expansion and could 
thereby avoid the common problem of immune rejection. 
 
Table 2. List of mouse and human resident CSCs based on the different markers expression55. 
 
Type of CSCs Other Markers References 
SCA1+ CSCs 
CD34-, CD45-, FLK1-, C-
KIT+/-, GATA4+, NKX2-
5+/-, MEF2C+ 
(Oh et al., 2003; Forte et al., 2008; Matsuura 
et al., 2004; Rosenblatt-Velin et al., 2005; 
Tateishi et al., 2007; Wang et al., 2006; Wu 
et al., 2006) 
C-KIT+ CSCs 
CD34-, CD45-, SCA1+, 
GATA4+, NKX2-5+, 
MEF2C+ 
(Bearzi et al., 2007; Beltrami et al., 2003; 
Dawn et al., 2005; Linke et al., 2005; 
Miyamoto et al., 2010; Tillmanns et al., 
2008; Urbanek et al., 2003) 
ISL-1+ CSCs CD31
-, SCA1-, C-KIT-, 
GATA4+, NKX2-5+ (Laugwitz et al., 2005; Moretti et al., 2006) 
Side population 
(SP) cells 
CD34+, CD45+, ABCG2+, 
SCA1+, C-KIT+, NKX2.5-
, GATA4- 
(Martin et al., 2004; Liang et al., 2010; 
Oyama et al., 2007; Pfister et al., 2005) 
Cardiospheres 
CD34+, CD45+, ABCG2+, 
SCA1+, C-KIT+, NKX2.5-
, GATA4- 
(Messina et al., 2004; Andersen et al., 2009; 
Cheng et al., 2010; Davis et al., 2010; Smith 




CD31+, CD34+, CD44+, 
CD45-, SCA1+, C-KIT+ 
(Barbuti et al., 2010; Galvez et al., 2008; 
Gálvez et al., 2009) 
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4.3 Skeletal muscle 
Skeletal muscle is a type of striated muscle tissue that is attached to the skeleton. Its 
contraction is under voluntary control, which differs from cardiomyocytes whose contraction 
is under involuntary control. 
Skeletal muscle is composed of thousands of cylindrical muscle units called “myofibers”, 
which are bound together by connective tissue and surrounded by vessels and nerves. 
Myoblasts are the basic unit of cells in the skeletal muscle that are able to fuse together to 
give rise to the mature functional cells called “multinucleated myofibers”. Each fiber contains 
several myofibrils, mitochondria and smooth endoplasmic reticulum (SER). The normal 
replacement of myoblasts and myofibers is acquired by the differentiation of so called 
“satellite stem cells”, the muscle resident stem cells located between basal lamina and 
sarcolemma.  
Due to the abundance of skeletal muscle in the body, satellite cells can be isolated and 
cultured, which allows for a convenient source of stem cells to be used in cellular and cell-
mediated therapies. Recent reports show that beside satellite cells, other types of 
stem/progenitor cells in the skeletal muscle exist56. In the following subsections, different 
stem/progenitor cells present in the skeletal muscle are described in detail. 
 
4.3.1 Muscle stem cells 
Satellite cells are considered as the skeletal muscle stem cells par excellence.  
They were described first in 1961 by Katz and Mauro41. The name “satellite” originated from 
their specific location within the fiber. Satellite cells reside between the sarcolemma and the 
basal lamina of the fiber but are separate from them. Their cellular origin is still unknown. 
Satellite cells are constituted by a heterogeneous population of mononucleated myogenic 
precursors that are quiescent and not proliferative. Upon injury, these satellite cells are 
activated and proliferate to regenerate the damaged muscle. It is known that during the normal 
lifespan of an organism, the capacity of the muscle to regenerate as well the number of 
satellite cells decreases with age57,58. Satellite cells can be identified by the expression of 
different molecular markers such as M-CADHERIN, C-MET, CD34, hepatocyte growth 
factor (HGF), myocyte nuclear factor (MNF) and PAX7, a paired box transcription factor59. 
Although satellite cells are considered bona fide muscle stem cells, recent reports reveal the 
presence of other populations of stem/progenitor cells in the skeletal muscle. These include 
PICs (Progenitor Interstitial Cells), mesangioblasts, pericytes, FAPs (Fibro-Adipogenic 
Precursor cells) and Muscle Derived Stem Cells (MDSCs).  
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PICS are muscle-resident stem cells, located in the interstitial space and express the cell stress 
mediator PW1 (or PEG3, paternally express 3). However, PICs do not express other typical 
skeletal stem cell markers such as PAX7. The presence or absence of these two genes (PW1 
and Pax7) accounts for the "P" in PIC. PICs are able to differentiate into muscle lineage in 
vitro and in vivo, are able to generate satellite cells and efficiently contribute to skeletal 
muscle regeneration but only in the presence of satellite cells60.  
Mesoangioblasts are cells related to the walls of large vessels. It has been shown that they 
possess the ability to differentiate into several types of mesodermal tissues (e.g. smooth, 
cardiac and skeletal muscle tissue, bone, fat). In contrast to pericytes, mesangioblasts are 
positive for the endothelial marker Flk-161. 
Pericytes are myogenic precursor cells that are associated with micro-vascular walls in the 
human skeletal muscle62. They may be reminiscent of embryonic ‘mesoangioblasts’ present 
after birth and they appear to be positive for alkaline phosphatase but not for Flk-1. 
FAPs (Fibro-Adipogenic Precursor cells), are another exclusive population of stem/progenitor 
cells that are able to interact with satellite cells to control the maintenance and regeneration of 
the skeletal muscle63,64. During regeneration, FAPs proliferate and produce different signaling 
molecules, including IL6, to stimulate satellite cells towards differentiation. During 
degeneration this secretion it is blocked and FAPs differentiate preferentially into adipocytes 
and fibroblasts, which inhibits proper myogenesis (the process of forming myofibers)65.  
MDSCs (Muscle Derived Stem Cells) may represent predecessors of satellite cells66. They are 
multipotent and can differentiate into bone, muscle, cartilage and adipose tissue. SCA1 has 
been consistently identified on the putative MDSCs as a marker67.  
 
All of the above-mentioned stem/progenitor cells express one common molecular marker, that 
is, Stem Cell Antigen 1 (SCA1). 
4.4 SCA1 as marker for stem cells 
In the field of stem cells, the most common way to isolate and identify stem cells is using 
molecular markers. These marker proteins are present on the surface of a cell. In general, to 
distinguish stem cells among the other cell types and to isolate them, instead of one marker, a 
combination of markers is used to achieve populations of target cells with a higher purity3. 
Among these markers, one of the most commonly used is Stem Cell Antigen 1 (SCA1). 
SCA1 is an 18kDa glycosyl-phophatidyl-inositol-anchored cell surface protein and belongs to 
the Ly6 gene family, which consists of at least 18 highly related genes present on mouse 
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chromosome 15. It was first identified on the surface of activated lymphocytes; thus SCA1 is 
also known as “Lymphocyte Activation protein-6”. Its protein is encoded by two allelic genes 
“Ly6E.1” and “Ly6A.2”68. It is suggested that SCA1 acts as a co-regulator of lipid raft 
signaling, which influences the decision making processes of the fates of stem cells. It is 
expressed in hematopoietic stem cells (HSCs) as well as in stem/progenitor cells of different 
organs and tissues, including liver, skeletal muscle, heart, prostate and mammary gland.  
In hematopoietic cells, SCA1 is involved in the down regulation of T-cell proliferation and in 
HSCs enrichment69,70. Concerning the heart, more than 93% of adult cardiac side population 
cells (SPs, one of the six different groups of CSCs) 71 express SCA1 while being negative for 
the hematopoietic cell marker CD45 and the endothelial marker CD34. Furthermore, Sca1-
positive cells were reported to play an important role in tissue regeneration after myocardial 
infarction72. In skeletal muscle, the presence of SCA1 as a cellular marker seems to have a 
role in myoblast differentiation, proliferation, fusion and cell-cycle exit. In particular, Sca1 




Figure 6. Sca1 as a stem cell marker.  
(a) Structure, distribution and function75. (b) A model in which the presence of Sca1 maintains homeostasis and 
self-renewal of myogenic cells, while the absence of Sca1 promotes differentiation of the myogenic cell pool76. 
 
4.5 Lineage tracing 
As described in Section 4.1.3.1 and illustrated in Figure 4, tissues and organs show different 
abilities to maintain homeostasis and renewal upon damage. These processes, in most cases, 
are achieved through the division and differentiation of stem/progenitor cells, although the 
capacity to renew differs from one stem cell type to the other. Due to the lack of robust stem-
cell-specific surface markers that can be used in various tissues and organs77, various 
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approaches have been developed to identify stem-cell-specific markers. Although up until 
now, no gold standard in the field of stem cells exists, one of the most promising approaches 
is called “lineage tracing”. Lineage tracing is a technique in which a cell is marked (e.g. with 
green fluorescence protein (GFP)). This mark should be transmitted to progenies of the target 
cell, if it is performed in a permanent lineage labeling manner78. Lineage tracing is an 
efficient tool to understand the characteristics of stem cells and their behaviors during normal 
development of an organism in their own environment (e.g. niches). Furthermore, when stem 
cells are labeled with a fluorescent protein (e.g. GFP) their fates can be monitored in real time 
even after isolation, transplantation into a host animal or when cultured in vitro.  
Currently, the following techniques are available to lineage trace the fates of the labeled cells: 
direct observation (or time-lapse microscopy), cell labeling, genetic markers, transplantation, 
genetic mosaic, genetic recombination (constitutional or inducible) and multiple reporters.  
- Direct observation is a non-invasive technique that is easy to handle and fast to establish. 
However, in the case of observing an entire organism, it is necessary to have only a small 
number of cells to be labeled in a transparent embryo or in a tissue that is easy to access. 
Commonly, this technique is used to follow cell division, motility and death of the cell in 
vitro78. 
- Cell labeling is used when it is not possible to perform direct observation. In this 
technique, the cells are labeled with vital dyes, such as carbocyanine dyes 
(indo/oxacarbocyanine e.g. Dil or DiO), or injected with fluorescein-conjugated dextran or 
horseradish peroxidase (HRP). With this technique, it is also possible to monitor the 
behavior of labeled cells, as was done in labeling DNA by C14 by Bergmann and 
colleague49. The disadvantages of this technique include the limitation of cell size and 
diffusion of dyes. When the cell is small for instance, it is difficult to inject the tracer. 
During cell division, the chemical compound will be diluted or diffused which is a 
problem for cells with high turnover if monitored for a long period of time as in the 
development of an organism. 
- Genetic markers (e.g. green fluorescence protein (GFP), ß-galactosidase or alkaline 
phosphatase) provide an alternative method of avoiding the spread of the dye to 
neighboring cells since these genetic markers are relatively stable and can be inherited by 
the progeny if the promoter that drives the expression of such marker has not been turned 
off79. The cell to label can be chosen “a priori” because the insertion will be random and 
the labeling can be introduced to cells by direct injection, transfection or viral infection. 
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However, this technique also has some limitations such as low introduction efficiency and 
spontaneous retroviral silencing.  
- Transplantation is suitable for clinical research which is mainly used to examine the 
fates of stem cells (e.g. bone marrow derived mesenchymal stem cells) in tissue like 
blood, muscle and skin80.  
- Genetic mosaic (e.g. chimeric mice) has been employed to investigate tissue 
organization81 as well as to understand the molecular basis of intercellular communication 
(a mixture of cell population in the cell culture)82. 
- Genetic recombination is the most elegant and refined way to lineage trace cells and was 
first used in the 1990s. This technique will be described in details in the next subsection. 
 
 
Figure 7. How to choose an appropriate lineage tracing strategy78. 
 
4.5.1 Genetic recombination 
Genetic recombination technique marks a cell permanently to allow further labeling of the 
tagged cell. It is one of the most commonly used tools to manipulate the genome of a target 
organism and to create knockout, conditional knockout and reporter animals (e.g. mouse). In 
genetic recombination, the following components are required: a switch and a reporter. 
 
4.5.1.1 The switch component 
The switch is achieved by using a Cre-recombinase. The name of this enzyme derived from 
the locus where it is encoded originally defined as “Causes recombination” or “Cyclization 
recombinase”83. 
Cre-recombinase protein and loxP sites are the two basic elements of the site-specific 
recombination mechanism present in the P1 bacteriophage. This phage normally infects 
bacteria (e.g. Escherichia coli), without integrating in their genome but rather existing as a 
plasmid. During its replication long multimeric DNAs are processed by Cre-loxP system in 
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order to create a circular monomeric one. This system helps to circularize the genomic DNA 
of the phage and facilitates its replication (Figure 8a)84. The loxP site consists of a 34-base 
pair (bp) sequence in which two flanking 13-bp inverted repeats are separated by an 8-bp 
spacer region. Cre-recombinase recognizes the loxP site at their flanking regions85 and in 
presence of two loxP sites promotes recombination generating free and catenated circular 
molecules86 (Figure 8b & c). Cre and loxP are not commonly found in the genomes of higher 
organisms, but they can be introduced into the target genome by transgenic technology in 
order to promote specific recombination. Depending on the orientation of the loxP sites, this 
system can be used to obtain a specific translocation, a large deletion (or a set of deletions), 
duplication or inversion of a target sequence. When two loxP sites are in the same orientation 
on a single chromosome it is possible to delete the flanking sequences (e.g. gene). When this 
strategy is used in the homologous chromosomes, it is possible to obtain duplication of the 
sequences. Furthermore, when loxP sites are inserted in the genome in an opposite orientation 
it leads to inversion of the target sequence in one chromosome (e.g. dicentric or acentric 
chromosome). When used in different chromosomes, translocation of the target sequence will 
happen (Figure 8c). 
The expression of Cre-recombinase can be controlled by targeting it to a specific promoter. 
For instance, promoters are often only active in a certain cell population (thus tissue-specific 
expression as in the case of alphaMHC in cardiomyocytes) or can be controlled using 
particular drugs (e.g. tetracycline (doxycycline)). The latter is very useful for controlling the 
expression postnatally by administration of the drug. Another possible system is based on the 
fusion of Cre-recombinase with the estrogen receptor responsive (ERT) element, which can 
be controlled by an injection of an estrogen receptor antagonist called “tamoxifen”. The latter 
system is called “Cre-ERT”87. The inducible systems mentioned above (with doxycycline or 
tamoxifen) will be clarified in the following paragraphs.  
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Figure 8. Cre-recombinase and loxP sites.  
(a) Cre-recombianse protein and loxP system present in the P1 bacteriophage84. (b) A scheme of a 
loxP site underlying the flanking regions recognized by Cre-recombinase and the 8bp core sequence 
where the recombination occurs85. (c) A DNA region flanked by two loxP sites with the same 
orientation promotes Cre-mediated excision producing circular and linear fragments86 . (d) Schemes of 
the different outcomes on the base of the loxP orientation88. 
 
4.5.1.1.1 Doxycycline inducible Cre system (Tet-Off and Tet-On) 
There are two ways of achieving Cre-based recombination using tetracycline or doxycycline: 
(1) tetracycline transactivator protein (tTA) known as “Tet-Off” or (2) reverse tTA (rtTA), 
known as “Tet-On”. In both cases, tTA is used to promote transcription of Cre-recombinase.  
The tTA protein is derived from the fusion between the tetracycline repressor protein (TetR) 
found in the bacterium Escherichia coli and the activation domain of VP16 protein from 
Herpes simplex virus. The obtained tTA binds the tetO operator sequence present in the 
tetracycline response element (TRE), which is located upstream of a modified CMV 
(cytomegalovirus) minimal promoter (Ptet1 promoter).  
In the Tet-Off system89, tTA binds the TRE and activates transcription in absence of 
tetracycline or its homologues (e.g. doxycycline). In presence of the drugs, tTA is not able to 
bind the operator and the transcription is repressed. The opposite situation happens in the Tet-
On system90. This system is based on rtTA protein (reverse tTA), that is derived from the 
modification of the amino acids sequence of the TetR present in tTA. The rtTA, different 
from tTA, depends on the presence of tetracycline or doxycline to be functional. The 
conformational change induced by the drugs, allows rtTA to bind TRE at the operator 
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sequence and promote transcription. In the Tet-On system, in the absence of drugs, 
transcription is repressed. Two other forms of Tet-On system exist: rtTA2s.M2 and Tet-On 
3G or rtTA-V10. They were developed by modifying the amino acids sequence of tTA which 
results in increased stability and sensibility for doxycycline by a factor of 10 and 100 
respectively91.  
 
Figure 9. Tet-Off and Tet-On systems92.  
(a) Tet-Off system. In the absence of doxycycline, tTA can bind the tetO operon, which allows for the 
transcription of Cre-recombinase to mediate recombination. In the presence of doxycycline, tTA changes its 
conformation, which is unable to bind the tetO sequences and to promote recombination. (b) Tet-On system. 
Only in the presence of doxycycline, rtTA can bind the tetO operon to allow for the transcription of Cre-
recombinase to mediate recombination. 
 
 
4.5.1.1.2 CreERT tamoxifen inducible system 
Another way to control Cre-mediated recombination is using “Cre-ERT” system. This system 
was derived from the fusion of Cre-recombinase to a modified version of the human estrogen 
receptor (ER)93. With this approach, it is possible to control the expression of Cre-
recombinase in the temporal manner by injection of an activator, the estrogen receptor 
antagonist tamoxifen. Cre-ERT complex is normally sequestered in the cytoplasm by heat 
shock proteins (HSPs) in an inactive form. In the presence of tamoxifen or its active 
metabolite 4-hydroxy-tamoxifen (4-OHT), the drug binds Cre-ERT leading to conformational 
changes and consequently the release of HSPs. This modification allows Cre-ERT 
translocation into the nucleus, where Cre-recombinase can recombine loxP sites and induce 
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the excision of the floxed gene. Since this system is very useful in controlling the expression 
of Cre-recombinase in a time- and tissue-dependent manner, various modifications of this 
system are available: mouse ERTM 94, human CreERT 95 and human CreERT2 96. Among these 
modifications, CreERT2 is more sensitive to tamoxifen regarding the nuclear translocation and 
shows a stronger recombinase activity, approximately ten times higher than CreERT 97. 
    
Figure 10. Cre-ERT system.  
(a) Schemes of the constructs used and the modified locus R26R; loxP sites are indicated by triangles. (b) In the 
absence of an appropriate ligand, the CreERT fusion protein (indicated as “Cre-ERT2” in the figure, which is the 
improved version of CreERT98) is bound to the heat shock protein. When tamoxifen (violet circles) is present, 
HSP90 dissociated from Cre-ERT and this causes the translocation of Cre-ERT into the nucleus, where it 
mediates the recombination using the loxP sites99. 
 
 
4.5.1.2 The reporter component 
The reporter component is a gene used as marker (e.g. beta-galactosidase) to determine the 
activity of another gene. In the Cre-loxP system, the reporter allows the visualization of Cre 
activity and the accuracy of the cell labeling. Two main approaches exist to follow reporter 
gene expression using Cre-mediate recombination technology. The first consists of a floxed 
stop cassette sequence (loxP-STOP-loxP) fused with an active promoter, that is upstream of 
the reporter gene. In this situation, in the absence of Cre-recombinase or when it is inactive, 
the transcription of the gene cannot occur and the cells will not be labeled. The presence of 
Cre-recombinase will recombine loxP leading to the excision of the stop cassette sequence. 
This removal allows the transcription of the reporter gene and the cells will be labeled.  
The second strategy is the possibility of switching the reporter line using Cre-recombinase in 
combination with a double-reporter system. In this case, a specific reporter gene (e.g. LacZ) 
followed by the stop cassette sequence are floxed and they are fused to a second reporter gene 
(ex GFP/ alkaline phosphatase). In normal conditions the cells express the first reporter but in 
the presence of Cre-recombinase the entire cassette, containing also the stop sequence is 
excised, allowing the expression of the second reporter gene (e.g. EGFP in Z/EG mice100). 
Different systems have been developed using either enzymes such as human alkaline 
phosphatase (e.g. Z/AP mice101) or fluorescence proteins (e.g. EGFP100, RFP102, tdtomato103) 
   INTRODUCTION 
24 
that are more suitable for three-dimensional confocal imaging. Furthermore, to follow the 
lineages of labeled cells with more than one reporter gene, multicolor reporters are available. 
(Brainbow104 or R26R-Confetti mouse105). These models are currently used in the research 
field to understand the origin and contribution of different cell types during the maintenance 
and repair of tissue105,106. 
 
 
Figure 11. An example of a reporter mouse.  
A representative scheme of a Z/EG100 reporter mouse. In this mouse two reporter gene are present: the floxed 
lacZ gene fused to a stop-codon cassette (ßgeo-3PA) and the enhanced GFP (EGFP) gene. The expression of 
both reporter genes is based on the activation of CMV-ß actin promoter. In absence of Cre-recombinase the cell 
is labeled with lacZ whereas the expression of Cre leads to the excision  of the floxed lacZ. This recombination 
will remove the fused stop codon cassette allowing the expression of EGFP.  
 
The lineage tracing techniques mentioned above are not only useful in tracing the fates of 
labeled cells but are also important in understanding the regulatory pathways that control the 
proliferation and differentiation of resident stem cells.  
Understanding these mechanisms will be not only help to ameliorate the manipulation or 
stimulation of resident stem cells but also to obtain reliable sources for stem cell therapy. 
However, in order for this to be possible a clear definition of the origin and status of resident 
stem cells is needed. 
 
   MATERIAL AND METHODS 
25 
5 MATERIAL AND METHODS 
5.1 Transgenic mice 
All animal experiments in this study were performed with approval of the local animal care 
committee. 
5.1.1 Sca1- tTA//LC1-Cre//Z/AP and Sca1- tTA//LC1-Cre//R26RConfetti  
Triple transgenic mice were obtained by breeding Sca1-tTA with LC1107 and Z/AP101 or 
R26R-Confetti105 reporter mice (Figure 12). Sca1-tTA mice were generated by pronucleus 
injection using standard procedures. Construction of the transgene was based on insertion of 
the tetracycline transactivator (tTA)-IRES-GFP-polyA cassette (~2.6Kb) into the ClaI cloning 
site of pPOLYIII-Ly6A in the first untranslated exon of Ly6a (Sca1) genomic region108. 
Genotyping was performed by PCR on tail DNA using the primers for tTA, Cre, R26RConfetti 
(Table 1). DNA was subjected to an initial five-minute denaturation at 94°C followed by 35 
cycles of denaturation (1 minute at 94°C), annealing (30 seconds at 55°C for tTA and Cre, 30 
seconds at 58°C for Confetti), and elongation (2 minutes at 72°C). LacZ staining of a tail was 
performed to reveal the presence of Z/AP allele.  
 
Figure 12. Mouse transgenic constructs.  
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5.1.2 Sca1-GFP 
Sca1-GFP (Ly-6A-GFP) mice were obtained as previously described108. Briefly, to create this 
mouse line, an enhanced GFP gene was inserted in the ClaI cloning site in the first 
untranslated exon of the Ly6a (Sca1) gene (Figure 2). Genotyping was performed by PCR on 
tail DNA using the GFP primers (Table 1). DNA was subjected to an initial five-minute 
denaturation at 94°C followed by 30 cycles of denaturation (1 minute at 94°C), annealing (2 
minutes at 55°C), and elongation (2 minutes at 72°C).  
 
 
Figure 13. Sca1-GFP transgenic mouse. 
Scheme of the 14-kb BamH1 fragment of the Ly-6A and the insertion of the GFP gene into the Cla1 cloning site; 
the following are the restriction site: B: BamH1; BG: BgIII; K: Kpn1; R: EcoR1, H: HindIII; X: Xba1108. 
 
5.1.3 Pax7-Cre//Z/AP  
The mice were obtained by breeding Pax7-Cre109 with Z/AP101 reporter mice. Pax7-Cre was 
created by using a targeting vector containing an IRES-Cre-FRT-Neo-FRT cassette within the 
3′-untranslated region of the Pax7 gene following the stop codon in exon 10 in the ClaI. 
Genotyping was performed by PCR on tail DNA using the primers for Pax7 and Cre, (Table 
1). For genotyping of Z/AP allele, LacZ staining of a tail was performed. DNA was subjected 
to an initial 5 minute denaturation at 94°C followed by 35 cycles of denaturation (1 minute at 
94°C), annealing (2 minutes at 58°C), and elongation (2 minutes at 72°C).  
 
 
Figure 14. Pax7-Cre//Z/AP transgenic mouse. 
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5.1.4 Sca1-tTA//LC1-Cre//Z/AP//mdx 
Mice were obtained by breeding Sca1-tTA//LC1-Cre//Z/AP with "X chromosome-linked 
muscular dystrophy" (mdx) mice110 (C57BL/10ScSn-Dmdmdx), a Duchenne dystrophy mouse 
model. Genotyping was performed by PCR on tail DNA using the primers for mdx (Table 1). 
DNA was subjected to an initial 3 minute denaturation at 94°C followed by 39 cycles of 
denaturation (1 minute at 94°C), annealing (1 minute at 50°C), and elongation (2 minutes at 
72°C). This procedure creates a new recognition site for the restriction enzyme MaeIII in the 
wild type but not in the mutant. The PCR products were then digested with 4 units of MaeIII 
at 54°C for 4 hours and separated on 4% agarose gel. 
 
 
Figure 15. Sca1-tTA//LC1-Cre//Z/AP//mdx transgenic mouse. 
Sca1-tTA//LC-1-Cre//Z/AP mouse was crossed with mdx mouse carrying a mutation in the dystrophin gene. The 




Mice were obtained by breeding Sca1-tTA//LC1-Cre//Z/AP with Pax7loxPGu/loxPGu (resulting in 
the deletion of exon1, 2 ,3 in the Pax7 locus111). Genotyping was performed by PCR on tail 
DNA using the following primers: tTA, Cre, Pax7loxPGu (Table 1) and Z/AP was checked as 
previously described (see section 5.1.1). For the Pax7loxPGu primers, DNA was subjected to an 
initial 3 minute denaturation at 94°C followed by 35 cycles of denaturation (30 seconds at 
68°C), annealing (1 minute at 50°C), and elongation (2 minutes at 72°C). 
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Figure 16. Sca1-tTA//LC1-Cre//Z/AP//Pax7loxPGu/loxPGu scheme.  




Table 3. List of Primers used for genotyping. 
 
 





















reverse 5'-GCCCGCTGTGTAGGAAAGCC -3' 
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5.2 Cell culture 
5.2.1 Murine adult cardiomyocytes 
Cardiomyocytes were isolated as previously published112. Briefly, mice were injected 
intraperitoneally with 0.5ml heparin diluted in phosphate buffered saline (PBS) to 100 IU/ml 
and anesthetized with isoflurane. After, the peritoneal cavity and chest were open with small 
scissors, the rib cage was carefully peeled back to expose the heart. Pulmonary vessels and 
aorta were dissected and the heart was collected in a 60-mm dish containing perfusion buffer 
(calcium free buffer: NaCl 113mM, KCl 4.7mM, KH2PO4 0.6mM, Na2HPO4 0.6mM, 
MgSO4x7H2O 1.2mM, NaHCO3 12mM, KHCO3 10mM, Hepes 10mM, Taurin 30mM, 2,3-
Butanedionemonoxime 10mM (B0753), Glucose 5.5mM) at room temperature. The heart was 
then attached to a burette, tying the aorta to the bottom of the column in order to start the 
perfusion. After 20 minutes of perfusion, the burette was re-filled with another 10ml of 
dissociation buffer (calcium free buffer, Liberase DH 0.14mg/ml (#5401089001, Roche), 
trypsin 0.14mg/ml, CaCl2 12.5µM). The perfusion was stopped once the heart became pale 
and no cardiomyocytes were visible in the flow through. The heart was collected in a 10mm 
dish containing 2.5ml of dissociation buffer and minced using forceps. The tissue was 
harvested in 2.5ml MC1 stop buffer (dissociation buffer, FCS 10%, CaCl2 12.5µM) and 
allowed to settle for 5 minutes. The supernatant was centrifuged at 300rpm for one minute. 
The supernatant was either collected as a non-cardiomyocyte fraction or discarded. Ten ml of 
MC2 stop buffer (dissociation buffer, FCS 5%, CaCl2 12.5µM) were added to the pellet. The 
calcium content was adjusted, every 4 minutes, with CaCl2 solutions at different 
concentrations (2 times 50µl 10mM, 100 µl 10mM, 30µl 100mM and 50µl 100mM). The 
cells were filtered with a cell strainer (Cell Strainer, 100µm Nylon, #352360, BD Falcon) and 
centrifuged at 300rpm for one minute. The supernatant was either collected with the previous 
non cardiomyocytes fraction or discarded while the pellet containing the cardiomyocytes 
fraction was re-suspended in culture medium (M199 w Earle Salt (3113, Gibco), 
CreatininexH2O 5mM (C3630, Sigma), L-CarnitinexHCl 2mM (C0283, Sigma), Taurin 5mM 
(T8691, Sigma), Hepes 25mM, 1% Penicillin/Streptomicyn, 10% FCS, 1% 
Insulin/Transferrin/Selenium  (I1884, Sigma)). Isolated cardiomyocytes were left to attach to 
chamber slides coated with laminin overnight at 37°C. The plates were coated with laminin at 
the concentration of 10µg/ml (BD Bioscience, cat. no. 354232) and incubated at 37°C for 2 
hours. Attached cardiomyocytes were processed for staining. 
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5.2.2 Cardiac stem cells (CSCs) 
Cardiac Stem Cells were isolated based on density gradient centrifugation using a commercial 
isolation kit (Millipore, Catalog #SCR061) following the manufacturer's protocol. Briefly, 5 
hearts from 2-3 month old C57BL/6 mice were washed in 10ml of cardiac stem cell isolation 
buffer (Millipore, Catalog #SCR061). The atria were dissected and discarded. The ventricles 
were minced into small pieces (approximately 1-2 mm in diameter) and collected in a 50ml 
centrifuge tube containing 6ml of dissociation buffer. The digestion of the tissue was 
performed for 45 minutes at 37°C at 150 rpm in Cardiac Tissue Dissociation Buffer. Tissue 
was subsequently dissociated using a 1000µl pipette for 2-5 minutes and further incubated for 
10 minutes at 37°C at 150rpm. The digestion was stopped using 24ml of Cardiac Stem Cell 
Maintenance Medium (Millipore, Catalog #SCR061). Cells were filtered using a Steriflip 
filter unit, centrifuged at 300g for 5 minutes and suspended in 945µl Cardiac Stem Cell 
Maintenance Medium. The re-suspended cell suspension was transferred to a new centrifuge 
tube and 2.055ml of Gradient Solution 1 was added. The suspension was carefully overlaid 
with 3ml of Gradient Solution 2 and subsequently centrifuged at 1500g for 10 min at room 
temperature. The upper phase of the cell mixture containing CSCs, was used for further 
experiments. 
 
5.2.3 Muscle derived stem cells (MDSCs) 
Mice (4-8 weeks old) were sacrificed by cervical dislocation. The hind limb muscles were 
dissected from the bones and collected in medium kept on ice. Tendons and ligaments were 
carefully detached under the microscope. The muscles were minced using scissors until 
homogeneous slurry was obtained. The muscle were enzymatically dissociated in DMEM low 
glucose containing dispase (Art.Nr.354235, BD Biosciences) for 30 minutes, followed by a 
digestion with 0.2% of collagenase-type I (Art.Nr.4176, Worthington Biochemicals) for 30 
minutes. The digestion was performed in a shaker chamber at 37°C with a speed of 500rpm. 
The muscle suspension was centrifuged at 1200rpm for 5 minutes and the tissue was 
mechanically dissociated using a 5ml pipette. To obtain a homogeneous cell suspension, the 
cells were filtered with 40µm cell strainer and centrifuged at 1200rpm for 5 minutes. Cells 
were suspended in DMEM low containing glucose, 10% FCS and 1% penicillin/streptomycin 
(P/S).The cell mixture contained muscle derived stem cells (MDSCs), which were used for 
further experiments.  
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5.3 Differentiation of cells 
5.3.1 In vivo assays 
5.3.2 Injections of BMP molecules 
The following bone morphogenetic proteins (BMP) molecules were used: hBMP4 
(Recombinant Human BMP-4 Heterodimer, R&D Systems, #314-BP/CF), hBMP7 
(Recombinant Human BMP-7 Heterodimer, R&D Systems, #354-BP/CF), hBMP4/7 
(Recombinant Human BMP-4/BMP-7 Heterodimer, R&D Systems, #3727-BP/CF). Proteins 
were reconstituted in 4mM HCl to a final concentration of 100µg/ml. In total, a volume of 
50µl of the suspension was used. BMP solutions were injected in the left anterior tibialis 
muscle of 3 month old Pax7-Cre//Z/AP and Sca1-tTA//LC1-Cre//Z/AP mice. The mice were 
sacrificed one month after injection and both anterior tibialis muscle (right and left) were 
collected and used for further experiments.  
 
5.3.3 Injection of glycerol 
To induce lipid formations63,64, a volume of 50µl of 50% (v/v) glycerol (Glycerol, Roth, 
7533) was injected in the left anterior tibialis muscle of the mice as previously described63,64.  
 
5.4 Pathological models  
5.4.1 Myocardial infarction and transverse aortic constriction 
Myocardial infarction was achieved by permanent ligation of the left anterior descending 
coronary artery as described previously113. Transverse aortic constriction was accomplished 
by applying a haemoclip (Weck) to the proximal aorta resulting in an acute left-ventricular 
pressure overload114. 
 
5.4.2 Muscle regeneration (cardiotoxin injection)  
To induce skeletal muscle regeneration, mice were injected with 50µl of 0.06µg/µl 
cardiotoxin snake venom (cardiotoxin from Naja mossambica mossambica, Sigma, C9759) 
into the left anterior tibialis muscle. The muscle was injected with cardiotoxin once per month 
for a total of three times. The injection was always performed in the left leg (tibialis anterior 
left, TAL) with the right one (tibialis anterior right, TAR) taken as control. Transverse 
cryosections were prepared and stained for alkaline phosphatase and laminin. 
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5.5 Histology 
5.5.1 Isolation of organs 
Mice were sacrificed by cervical dislocation.  
The peritoneal cavity was opened and the diaphragm was punctured collapsing the lung. The 
chest was cut and the heart was quickly collected, washed in 1X PBS to remove excess blood. 
Then, the heart was directly snap frozen in liquid nitrogen. 
The anterior tibialis muscle was collected by cutting the skin of the leg above the heel. The 
skin was pulled over the hips to expose the muscles. The muscles were collected carefully by 
cutting the tendons at the extremities. The isolated skeletal muscle was frozen in pre-cooled 2-
methylbutane prior to embedding in tissue tek. For Sca1-GFP and R26R-Confetti mice, the 
tissues were fixed overnight with 4% paraformaldehyde (PFA). Tissues were kept in -80°C 
until further usage. 
 
5.5.2 Cryosections 
Sections of 6~8µm thickness were prepared on a cryostat (Leica CM3050). After air drying 
for 30 minutes, sections were kept at -80°C for further usage. To avoid degradation of 
proteins, sections were processed within one week. 
 
5.6 Immunohistochemistry 
5.6.1 Detection of alkaline phospathase activity 
Cells or cryosections were fixed with 0.4% glutaraldehyde at room temperature for 5 minutes, 
washed two times with PBS, heated at 70°C for 30 minutes in PBS, and incubated in NTMT 
buffer (100mM NaCl, 100mM Tris-HCl pH 9.5, 50mM MgCl2, 1% Tween-20 and 2mM 
Levamisol) at room temperature for 30 minutes. The color was developed using ready-to-use 
NCT/BCIP tablet (ref.11697471001, Roche) or a staining solution (168mg 4-Nitroblue 
tetrazolium (NBT) and 84.5mg 5-Bromo-4-chloro-8-indolilphosphate (BCIP) for each ml of 
NTMT) at 37°C for at least 2 hours. The reaction was quenched by washing with PBS. A 
negative control was included in all the stainings. 
 
5.6.2 Trichrome staining 
Cryosections were let dry for 30 min at RT. The section were stained using the Trichrome 
Masson kit (Trichrome stain (Masson) Kit, HT15, Sigma). Briefly, they were rinsed in ddH2O 
for 1-2 minutes to remove the OCT in excess and incubated at 56 C for 15 minutes in 
preheated Bouin’s Solution. After the incubation, the slides were washed first in running tap 
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water for 20-25 minutes and then 3 seconds in ddH2O. They were then subsequentially 
incubated in the following solutions: 1) 5 minutes in Mayer’s hematoxylin (Haemalaun) to 
stain the nuclei; 2) 5 minutes in Biebrich Scarlet-Acid Fuchsin solution; 3) 5 minutes in 
working Phosphotungstic/Phosphomolybdic acid/ddH2O solution (1:1:2); 4) 5 minutes in 
Anilin Blue solution; 2 minutes in acetic acid 1%. Between each step the slides were washed 
with running tap water for 5 minutes and for three seconds in ddH2O. The sections were then 
dehydrated in different alcohol solutions: 90% ethanol for 2 seconds; 96% ethanol for 2 
seconds; two times 100% ethanol, each time 2 minutes. As last step the sections were fixed 2 
times in xylene for 10 minutes and mounted with Entellan (Entellan®, 107960, Merk). 
 
5.6.3 Oil red O (OrO) 
To detect triglycerids, lipids and lipoproteins, Oil red O was used. 
Oil red O was dissolved in isopropanol (0,5%). Six ml of this solution were then diluted with 
4ml of ddH2O and left at room temperature for one hour to obtain the working solution. To 
peform Oil red O staining, cryosections were fixed one hour with 4% PFA at 4°C. After 
washing with tap water, the sections were incubated in Oil red O staining solution for 15 
minutes at room temperature. The nuclei were counterstained with hematoxilin for one minute 
at room temperature.  
 
5.6.4 Alizarin red 
To detect calcium deposits, Alizarin red was used at the concentration of 2%  suspended in 
distilled water. Cryosections were fixed with 4% PFA at 4°C for one hour.  
After washing with tap water, the sections were stained with the Alizarin red solution at room 
temperature for one minute. Tap water was used to stop the reaction. The sections were then 
rinsed in acetone/xylene 1:1 for 15 seconds and in xylene one minute.  
 
5.7 Immunofluorescence analyses 
5.7.1 Antibody staining 
Cells or cryosections were fixed in 4% PFA at room temperature for 5 minutes. The sections 
were washed 3 times with PBS, followed by a permeabilization step with 0.1% or 0.5% Triton 
X-100/PBS at room temperature for 5 minutes, when necessary. A primary antibody was 
diluted in PBS and incubated at room temperature for one hour or at 4°C overnight. The list of 
the antibodies used is provided below (Table 4). After incubation with primary antibody, the 
sections were washed three times with PBS, followed by incubation with the relative 
secondary antibody at room temperature for one hour. The dilutions of secondary antibodies 
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with PBS were as follows: 1:100 when coupled with FITC, GFP, CY2 (green), biotinylated 
antibodies, anti-streptavidin-Alexa633 (far red) and 1:300 when with TRITC, PE, CY3 (red). 
The nuclei were counter stained with DAPI (D1306, Molecular Probes, Invitrogen) diluted 
1:1000 in PBS. The coverslip was mounted with Mowiol (Mowiol® 4-88, Art.-Num. 0713, 
Carl Roth) and left dry at 4°C before proceeding to microscopy. Counting and pictures were 
done using a Leica LEITZ DM RB, Camera: Leica DFC 300FX, Axioplan2, HBO100 Zeiss 
and Leica SP2-AOBS confocal microscope.  
 
5.7.2 Immunofluorescence staining and cells counting 
For the heart, at least 10 slides containing serial sections were prepared. Slides were incubated 
with antibodies against BS-1, dystrophin, α-smooth muscle actin, Triticum vulgaris lectin 
TRITC conjugate, and with NBT/BCIP staining solution (to check the specificity and 
efficiency of anti-human alkaline phosphatase placental (hPLAP) antibody staining). Cell-
type-specific antibody labeling was performed together with anti-hPLAP antibody and the 
nuclei were counterstained with DAPI. To calculate the percentage of cell types, the number 
of hPLAP+/cell-type-marker-positive cells was divided by number of hPLAP+/ lectin-positive 
cells. To derive P-values, the Wilcoxon Mann-Whitney Test was applied in R. Results are 
presented as mean ± s.e.m. 
For muscle, at least 16 consecutive cross sections were made. In addition to anti-hPLAP 
antibody, the muscle tissue was stained with dystrophin, laminin and the nuclei were 
counterstained with DAPI. The number of cells/mm2 was obtained by measuring the area of 
each section with ImageJ. The percentage of the fibers was calculated by using “2088” as a 
total number of fibers present in an anterior tibialis muscle of a mouse115. To derive P-values, 
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Table 4. Table of antibodies. 
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5.7.3 Confocal microscopy and three-dimensional (3D) reconstructions 
Sections were examined by laser scanning confocal microscopy (Leica TCS SP2, AOBS). 
After data acquisition, the images were transferred to Silicon Graphics Indy workstation 
(Silicon Graphics) for three-dimensional (3D) reconstruction using Imaris, the 3D multi-
channel image processing software (Bitplane, Zürich, Switzerland) as described by Kostin et 
al.116. 
 
5.7.4 Fluorescent in situ hybridization (FISH) 
Isolated cardiomyocytes were stained with mouse IDetectTM Chromosome Y FISH Paint 
Probe Red (Labs Inc Biotechnology) as described previously117. Briefly, slides were fixed in 
4% PFA and dehydrated in 70, 80, and 100% ethanol for one minute each. The mouse paint 
probe and hybridization mixture were mixed at a ratio of 3:7. The mixture was applied to the 
cells, covered with a plastic coverslip, glued with rubber cement, and denatured at 69°C for 2 
minutes and allowed to re-anneal for 16 hours at 37°C. The next day two post hybridization 
washes were done, using the following solutions: 2X SSC and 0.2% Tween at room 
temperature, 0.4X SSC and 0.2% Tween at 73°C for 2 minutes, and 2X SSC at room 
temperature for one minute. Immunofluorescence staining of FISH-hybridized cells was 
performed as described above. The following antibodies were used: rabbit human placental 
alkaline phosphatase (1:50, Axell), goat anti rabbit CFTM488 (1:100, Biotium), AlexaFluor633 
phalloidin (1:300, Invitrogen). Nuclei were stained with DAPI at room temperature for 5 
minutes. Pictures were taken using a Leica SP2-AOBS confocal microscope. 10 randomly 
selected fields were examined and counted. 
 
5.8 Fluorescence-activated cells sorting (FACS) 
5.8.1 FACS 
Cells were isolated and contaminating red blood cells were removed by incubating the single 
cell suspension in sterile filtered de-ionized water at 25°C for one minute followed by two 
washing steps with PBS. The resulting cell suspension was pre-incubated with blocking rat-
mouse antibodies to the FcRγ III/II receptor (clone 2.4G2; BD Biosciences, Catalog #553141) 
before staining with primary antibodies. The following conjugated primary antibodies were 
used: fluorescein isothiocyanate mouse CD45.2 (anti-CD45.2; clone 104; eBioscience, 
Catalog #11-0454), phycoerythrin-conjugated anti-CD45 (30-F11; BD Biosciences, 
#553081), peridinin chlorophyll protein-eFluor710 conjugated anti-CD31 (clone 390; 
eBioscience, Catalog #46-0311), allophycocyanin-conjugated anti-SCA1 (Ly-6A/E, clone D7; 
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eBioscience, Catalog #17-5981), SM/C2.6 biotinylated (gift from professor Soichiro Fukada, 
Japan), allophycocyanin-conjugated anti-Streptavidin (BD Bioscience, Catalog #554067), 
PDGFRalpha (anti-mouse CD140a, clone APA, eBioscience, Catalog#17-1401) (Table 4). 
Cells were analyzed and sorted as single cells into a 96-well plate using a MoFlo-cytometer 
(BeckmanCoulter). Data were analyzed with FlowJo software (TreeStar). 
 
5.8.2 Cell populations isolated by FACS 
In the heart SCA1+CD31-CD45- cells were isolated. 
In the skeletal muscle different populations were considered: SM-C2.6+SCA1+CD31-CD45-, 
SM-C2.6+SCA1-CD31-CD45-, PDGFRalpha+SCA1+CD31-CD45-, PDGFRalpha+SCA1-
CD31-CD45-, SM-C2.6-SCA1+CD31-CD45- and PDGFRalpha-SCA1+CD31-CD45- cells. 
 
5.8.3 Cytospin 
After sorting, cells were cyto-centrifuged at 700rpm for 5 minutes using a Shandon Cytospin 
2 Centrifuge (Block Scientific). Slides were fixed with 4% PFA for 5 minutes and air-dried at 
room temperature. The slides were stored at -80°C until further usage. 
 
5.9 Molecular biology and single cell analyses 
5.9.1 Microarray analyses 
RNA was isolated using TRIzol reagent (Life Technologies) and processed for microarray 
experiments as described previously118. After scanning of the arrays, CEL files were up 
loaded to previously described web interfaces: (1) “Exon Array Analyzer (EAA)” 
(http://eaa.mpi-bn.mpg.de/)119 for GeneChip® Exon 1.0 ST Arrays (Affymetrix) (called “exon 
array”); and (2) “Gene Array Analyzer (GAA)” (http://gaa.mpi-bn.mpg.de/)118 for 
GeneChip® Gene 1.0 ST Arrays (Affymetrix) (called “gene array”). Multi-Array Average 
(RMA)120 normalized values were utilized for further analyses using R (http://cran.r-
project.org/) for statistical analyses, MultiExperiment Viewer (MeV)121 for hierarchical 
clusterings as well as heatmaps and TreeGraph 2122 for visualization of clustering trees. 
For comparison of gene arrays, the following datasets deposited at the Gene Expression 
Omnibus (GEO) were used: (1)GSE14414:  "eCardio.1", "eCardio.2", "eCardio.3" for 
murine embryonic cardiomyocytes and "eCFibro.1", "eCFibro.2", "eCFibro.3" for murine 
embryonic cardiac fibroblasts123; (2) GSE20991: "eKEndo.1", "eKEndo.2", "eKEndo.3" for 
endothelial cells from kidneys of Tie2-GFP transgenic mice124; (3) GSE22292: "nCardio.1", 
nCardio.2" , "nCardio.3" for murine neonatal cardiomyocytes and "nCFibro.1" , 
"nCFibro.2" , "nCFibro.3" for murine neonatal cardiac fibroblasts125; (4) GSE20991: 
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"aCFibro.1", "aCFibro.2", "aCFibro.3" for murine adult cardiac fibroblasts124; (5) 
GSE21324: "aKEndo.1", "aKEndo.2", "aKEndo.3" for glomerular endothelial cells from 
adult Tie2-GFP mice124; (6) GSE34948: "Endo.N.1", "Endo.N.2" for endothelial cell lines 
derived from murine embryonic stem cells expressing N-cadherin; "Endo.VE.1", 
"Endo.VE.2" for endothelial cell lines derived from murine embryonic stem cells expressing 
VE-cadherin; and "Endo.VE+N.1", "Endo.VE+N.2" for endothelial cell lines derived from 
murine embryonic stem cells expressing both N-cadherin and VE-cadherin126. Furthermore, 
(7) sample data sets of murine adult hearts ("aHeart.1", "aHeart.2", "aHeart.3") were 
downloaded from Affymetrix118. The followings data sets generated in our laboratory were 
added: (8)Undifferentiated murine ES cells: “ES.1” and “ES.2”118; and (9) Adult bone 
marrow-derived multipotent mesenchymal stem cells (BM-MASCs): "MASC.1" for clone #1 
and "MASC.2" for clone #2113. All data sets were analyzed at once using the GAA web 
interface to minimize biases. 
 
5.9.2 Single cell analysis 
To perform single cell quantitative RT-PCR experiments the BioMarkTM HD System 
(Fluidigm Inc.) was utilized.  
Different populations were considered in heart and muscle based on SCA1 expression. In the 
heart SCA1+CD31-CD45- cells were used. In the muscle SM-C2.6+SCA1+CD31-CD45-, SM-
C2.6+SCA1-CD31-CD45-, PDGFRalpha+SCA1+CD31-CD45-, PDGFRalpha+SCA1-CD31-
CD45- populations were sorted. Single cells from each population were sorted into individual 
wells of a 96-well plate containing 5µl of Cells Direct 2X Reaction Mix (Life Technologies, 
Catalog # PN11753) with 0.05 units of RNase inhibitor. Care was taken to deliver only single 
cells into individual wells. Plates were centrifuged after sorting and immediately frozen on 
dry ice and stored at -80°C until further usage. Frozen plates were thawed on ice before 
reverse transcription according to the Fluidigm manual with the following modifications. In 
the heart, for pre-amplification, a primer mix consisting of 436 primer pairs (263 genes and 
one non-coding RNA (ncRNA) (Airn)) was used, in the muscle 576 primer pairs (288 genes) 
were used. The final concentration of each primer was 437nM for CSCs and 1052nM for 
skeletal muscle populations. All primers were designed to span two exons to prevent 
amplification of contamination genomic DNA. All primers were tested for the presence of 
single PCR products on agarose gels and for a single peak in the melting curve analysis using 
cDNA as templates using an iCycler (BioRad) in the presence of SYBR Green I for 40 cycles 
of amplifications. The cDNA was obtained from murine adult heart and murine adult skeletal 
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muscle. The number of cycles for the Reverse Transcription (RT)-Specific Target 
Amplification (STA) (STA-RT) was 20. 
The following control samples were prepared: undifferentiated ES118, P19CL6127, CSCs and 
C2C12. To assess the performance of the reaction, 100, 10 and 1 cells were prepared from 
each of the above mentioned cell types. The buffer without cells was used as a negative 
control. For SCA1+CD31-CD45- CSCs sorted cells, 96 single cells were prepared. For the 
muscle samples 182 single cells were chosen among the following different populations: SM-
C2.6+SCA1+CD31-CD45- (32 cells), SM-C2.6+SCA1-CD31-CD45- (32 cells), 
PDGFRalpha+SCA1+CD31-CD45- (31 cells), PDGFRalpha+SCA1-CD31-CD45- (23 cells). 
After pre-amplification, samples were treated with exonuclease I to remove possible 
unincorporated primers and diluted 10-fold. For quality control, 1µl of each of the diluted 
samples was used for real-time RT-PCR reactions in the iCycler (Biorad) using EvaGreen 
DNA binding dye (Biotium, Catalog #PN31000) and primer pairs against Ly6a, Pax7, 
Pdgfralpha were considered to monitor successful samples preparation. All samples passed 
this quality check and were used for each 96.96 Dynamic Array IFC. 
After the data were generated of data, samples with no Ct value for endogenous control genes 
(Actb and Gapdh) and with high variation in Ct values, among three independent 
measurements of Actb, were excluded from further analysis. As a result, 74 heart samples and 
106 muscle samples [SM-C2.6+SCA1+CD31-CD45- (29 single cells), SM-C2.6+SCA1-CD31-
CD45- (29 single cells), PDGFRalpha+SCA1+CD31-CD45- (31 cells), PDGFRalpha+SCA1-
CD31-CD45- (17 single cells)] were selected for further analyses.  
The data were normalized as previously described128. Briefly, all the Ct values were converted 
into relative expression levels by subtracting the values obtained from the assumed baseline 
40 (number of cycles used in the PCR reaction). Samples without Ct value were set to “0”. 
The gene values were then normalized to the endogenous control by subtracting the Actb 
expression level to derive geometric means on a linear scale128. Finally, these normalized 
values were used to calculate “delta delta Ct (ddCt)” values.  
The following filter was applied to uncover the heterogeneity of SCA1+CD31-CD45- single 
cells: if for a certain gene the Ct value was detected in less than 7 cells (10% of 74 
SCA1+CD31-CD45- single cells), the gene was removed from analysis. This filtering step left 
a total number of 103 genes, which was used to create a matrix of 74 SCA1+CD31-CD45- 
single cells x 103 genes.  
In order to understand the molecular signatures of single cells, ddCt of internal controls were 
derived and were used for further normalization. The following cell types consisting of 100 
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cells were used as internal controls: undifferentiated ES cells, P19CL6 cells, and CSCs for 
CSCs and C2C12 cells and MDSCs for the muscle. Furthermore, in the case of skeletal 
muscle, the populations SM-C2.6+SCA1-CD31-CD45-(A), SM-C2.6+SCA1+CD31-CD45-(B), 
PDGFRalpha+SCA1-CD31-CD45-(D), PDGFRalpha+SCA1+CD31-CD45-(E) were compared 
using the student T test (2 tails and 2 sample unequal variance) to distinguish if the presence 
of SCA1 could mark a separation at the gene expression level.  
The hierarchical clustering and heatmaps were generated using the MultiExperiment Viewer 
(MeV)121. The data were analyzed using the nine different clustering algorithms (Hierarchical, 
K-means, DIANA, PAM, CLARA, FANNY, SOM, mclust and SOTA) present in the R 
package clValid. 
   RESULTS 
41 
6 RESULTS 
6.1 Identification and analyses of resident cell populations in the 
heart and their contribution to cardiac tissue renewal  
 
6.1.1 Sca1 progenitors cells are detected in vivo during normal physiological 
conditions 
 
The presence of resident stem cells in the heart and in other organs and tissues has become 
apparent over the past years. Different populations of cardiac resident stem cells have been 
described in the literature based on the expression of different markers55. One population 
among them has been defined as being positive for stem cell antigen 1 (Sca1/Ly6A)71,129. 
However, to date, its contribution in vivo has not been clearly elucidated.  
In order to investigate the role of these resident stem cells and in particular the contribution of 
Sca1 progenitor cells in heart regeneration in vivo, the Sca1-tTA//LC-1-Cre//Z/AP triple 
transgenic mouse system was utilized (Figure 12a). In Sca1-tTA//LC-1-Cre//Z/AP mice, the 
cells that have expressed and express Sca1 were labeled with human alkaline phosphatase 
(hPLAP). Briefly, in this mouse model, tetracycline transactivator (tTA) is under the control 
of the Sca1 (Ly6a) promoter. Once expressed, tTA can interact with the Ptetbi-1 promoter, 
present in the LC1-Cre locus, consisting of a bidirectional transcription unit able to encode for 
Cre and the luciferase genes. The recruitment of tTA to the Ptetb-1 promoter stimulates the 
transcription of Cre-recombinase. The Cre will recombine the loxP-sites present on the Z/AP 
locus. In this reporter mouse the lacZ gene, fused with a stop codon cassette, is floxed by two 
loxP sites and is upstream of the human placental alkaline phosphatase gene (hPLAP). In the 
absence of Cre, the lacZ gene is transcribed, and due to the stop codon the expression of 
hPLAP does not take place. When Cre is transcribed from LC1 allele, the recombination of 
the loxP sites can take place leading to the excision of lacZ together with the stop cassette and 
allowing the expression of hPLAP.  
In order to address whether in cardiac tissue a population of cells derived from Sca1 
progenitor cells is present, the hearts of mice from 2 to 18 months old were subjected to 
immunohistochemistry to detect alkaline phosphatase activity (Figure 17a). Furthermore, 
immunofluorescence staining was performed to detect the type of cells Sca1 progenitors are 
able to give rise to. Human placental alkaline phosphatase antibody (AP) was combined with 
BS-1 to detect interstitial cells, with alpha smooth muscle actin for smooth muscle cells or 
with dystrophin for cardiomyocytes (Figure 17b). The percentage of the different Sca1-
derived cells types was calculated by normalizing the number of Sca1-derived cells positive 
for lectin (from Triticum Vulgaris), a marker labeling all cellular membranes and 
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consequently all the AP+-cells present in the sections. Counting revealed a constant proportion 
in the distribution of the three major cell types present in the heart during aging. The great 
part of cells expressing AP was constituted by endothelial/interstitial cells (an average of 
87.48%), whereas a small portion by cardiomyocytes (2.97%) and smooth muscle cells 
(1.65%). When the number of counted cells was normalized to the area of a section (cells per 
mm2) a linear increase in the number of AP+-cardiomyocytes was observed from the age of 2 
months to 18 months (Figure 17c & d). The presence of endothelial cells, smooth muscle cells 
and cardiomyocytes positive for AP confirms that Sca1 progenitor cells can give rise to these 
lineages. Furthermore, the increased number of AP+-cardiomyocytes during aging suggests 
that Sca1 progenitor cells contribute to heart regeneration. 
 
 
Figure 17. Sca1 progenitor cells in vivo.  
(a) Alkaline phosphatase staining of 2 months old Sca1-tTA//LC1-Cre//Z/AP murine heart. The staining shows a 
broad and random distribution of the Sca1+ progenitor cells and their descendants. (b) Examples of 
immunofluorescence staining of endothelial/interstitial cells (BS1 in red), smooth muscle cells (alpha smooth 
muscle actin in red) and cardiomyocytes (dystrophin in red). The AP+-labeled cells were shown in green. (c) 
Distribution of labeled cells in the three different cells types: about 87.48% were endothelial cells, 2.97% 
cardiomyocytes and 1.65% smooth muscle cells. The percentage was obtained counting the number of cells in 
consecutive sections of mice with an age between 2 and 18 months. Markers specific for endothelial cells, 
smooth muscle cells and cardiomyocytes were considered. (d) The number of cardiomyocytes per mm2 presents 
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6.1.2 Sca1 progenitor cells contribute to cardiomyocyte renewal under 
pathological conditions 
 
During aging in the heart of Sca1-tTA//LC-1-Cre//Z/AP mice, it was possible to detect AP+-
cells belonging to the all three major lineages as well as an increased number of 
cardiomyocytes expressing AP. These results suggest the possibility that a Sca1-expressing 
cell population contributes to the maintenance of cardiac homeostasis under normal 
physiological conditions. However, recently it was reported that cardiac stem cells play an 
important role in cardiac regeneration in response to damage48. Therefore the contribution of 
endogenous Sca1-expressing cells to myocardial regeneration was investigated under 
pathological conditions. For this purpose, the following two injury models were used: 
myocardial infarction and transverse aortic constriction (TAC). 
In the first model, 3 month old mice were subjected to permanent ligation of the left anterior 
descending coronary arteries (LAD) to induce myocardial infarction (MI). Although a relative 
decrease of AP+-cells in the infarcted area and in the border zone was observed (Figure 18a & 
b), clusters of AP+-BS-1 expressing endothelial/interstitial cells were found in the septum. 
Overall, the number of AP+-cardiomyocytes remained constant in the post-MI heart (Table 5). 
In the second model, pressure-induced cardiac hypertrophy was induced by performing 
transverse aortic constriction (TAC). This strategy was used to test whether this damage could 
promote the generation of new Sca1-derived cardiomyocytes. First, AP staining was 
performed to obtain an overview of the AP+-cells distribution within the heart of Sca1-
tTA//LC1-Cre//Z/AP mice after the damage (Figure 18c). All mice were challenged by TAC 
at the age of 3 months. Four weeks after TAC-operation, despite the fact that the total number 
of AP-labeled cells did not change significantly (18.68±6.40 cells/mm2 for TAC-operated 
hearts and 13.79±6.50 cells/mm2 for the aged matched hearts; P=0.74), the number of AP+-
cardiomyocytes increased more than three-fold (0.17±0.06 cells/mm2 and 0.57±0.10 
cells/mm2 for the aged-matched and TAC-operated hearts, respectively; P=0.03) (Figure 18d). 
Five months after TAC-operation, the number of AP+-cardiomyocytes increased two fold 
compared to the sham operated mice (0.84±0.49 cells/mm2 for TAC-operated hearts and 
0.4±0.15 cells/mm2 for the aged matched hearts; P=0.5) and the total number of AP+-cells 
(compared to the age-matched 8-month old hearts) increased three fold (45.15±7.46 cells/mm2 
for TAC-operated hearts and 15.23±2.94 cells/mm2 for the aged matched hearts; P=0.05).  
These data suggest that the Sca1-expressing cells are involved in myocardial regeneration 
after damage and the type of damage might influence the fate decisions of Sca1-expressing 
cells in heart regeneration. 
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Figure 18. Sca1 progenitor cells contribution in vivo under pathological conditions (myocardial infarction 
and transverse aortic constriction).  
(a) Trichrome staining of a representative section of four month old Sca1-tTA//LC1-Cre//Z/AP mice, one month 
after LAD ligation. (b) Triple labeling of areas from different regions of post-infarcted hearts stained for 
collagen I (red), AP (anti-hPLAP antibody, green), and nuclei (DAPI, blue). The numbers indicate the different 
regions of the operated heart as indicated in the picture (b). Areas bordering the scar (1, 4) identified by massive 
deposition of collagen I or within the scar (3), show a reduction of Sca1-derived cells. An increase in Sca1-
derived cells (green) was found in areas showing a compensatory hypertrophy (4). (c) AP-staining of cross-
sections of 4 and 8 months old Sca1-tTA//LC1-Cre//Z/AP sham operated mice (control) and relative age-
matched mice subjected to TAC at 3 months old (TAC). (d) Numbers of total AP+-cells and AP+-
cardiomyocytes per mm2 in hearts of TAC-operated and control mice at 4 and 8 months of age. 
 
Table 5. Distribution of labeled cells after myocardial infarction. 
 
 
Percentage of Sca1-derived (AP+) 
endothelial/interstitial cells (BS-1+), 
cardiomyocytes, (dystrophin positive), 
and smooth muscle cells (alpha smooth 
muscle positive) at 4 months of age 
without and after myocardial infarction. 
LAD was performed at 3 months of 
age. Percentages were calculated by 
dividing the number of specifically 
labeled cells (e.g. dystrophin-positive 
cells) by the number of lectin-positive/ 
AP+-cells, representing the total 
number of AP-labeled cells in the heart. 
SEM values and sample numbers are 
indicated. All labeled cells in the 
respective sections were counted.
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6.1.3 The presence in vitro of mononucleated cardiomyocytes reinforces the 
contribution of progenitor cells to heart self-renewal 
 
The heart has long been considered a post mitotic organ unable to self-renew. However, 
recently it has been shown that, although at a low rate, the heart exhibits a certain turnover36. 
Two hypotheses have been proposed to explain the possible cellular source responsible for 
this renewal. The first sustains the presence of common resident precursor or stem cells 
(called “cardiac progenitor/stem cells (CSCs)”)130-132, that are able to differentiate and give 
rise to new cardiomyocytes. The second claims that existing cardiomyocytes are able to re-
enter the cell cycle, divide again and originate new cardiomyocytes133,134. Cardiomyocytes are 
defined to be terminally differentiated cells presenting more than one nucleus135. However, 
the presence of cardiomyocytes with one nucleus in the heart, could lead to the assumption 
that these mononucleated cells are derived from CSCs rather than from pre-existing 
multinucleated cardiomyocytes. In order to understand if mononucleated cardiomyocytes are 
present in the mouse heart and their distribution during aging, cardiomyocytes were isolated 
from the hearts of 3, 6, 18 and 21 month old C57BL/6 mice. The number of mice considered 
for each group was a minimum of three. The cells were stained with phalloidin, which 
provides a general overview of the myocardial morphology whereas DAPI was used to 
visualize the nuclei (Figure 19a). Ten random pictures were taken from different fields of the 
slides to achieve an unbiased, statistically-sounds analysis. In each field, the number of nuclei 
present in each cardiomyocyte was counted. As shown in Figure 19b, from the age of 3 to 21 
months, the majority of cardiomyocytes were found to be binucleated (3 months: 
73.91%±4.05; 6 months: 68.90%±5.61; 9 months: 63.05%±3.66; 21 months: 59.54%±4.86). 
In comparison mononucleated cardiomyocytes were detectable at a constant level until the 
age of 6 months, while they increased approximately 17% in 6 to 9 month old mice, (3 
months: 21.48%±2.22; 6 months: 21.34%±1.96; 9 months: 34.19%±3.01; 21 months: 
33.97%±3.54). A small percentage of cardiomyocytes, of about 4.71%, were trinucleated (3 
months old: 2.81%±1.35; 6 months old: 7.15%±1.15; 9 months old: 2.39%±0.68; 21 months 
old: 6.49%±1.52), while tetranucleated cardiomyocytes were found in 3 and 6 month old mice 
(3 months old: 1.79%±0.71; 6 months old: 2.44%±0.69) (Figure 19b). These data suggest the 
presence of a constant number of mononucleated cardiomyocytes in vitro during aging.  
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Figure 19. Number of nuclei in cardiomyocytes.  
(a) Cardiomyocytes were freshly isolated from 3, 6, 9, 21 month old C57BL/6 mice. After overnight culture, 
they were stained with Phalloidin TRITC (in red) and the nuclei counterstained with DAPI (in blue). (b) 
Summary of the number of cardiomyocytes counted at different ages discriminating on the base of the number of 
nuclei detected. Although a majority of cardiomyocytes turned out to be binucleated, a substantial increase in the 
number of mononucleated cardiomyocytes from the age of 6 to 9 months was observed. 
 
6.1.4 Identification of newly regenerated cardiomyocytes not derived from 
fusion events 
 
The identification of mononucleated cardiomyocytes and their increase during aging suggest 
the possibility of the existence of newly generated cardiomyocytes. However, it is known that 
cardiomyocytes as well as hepatocytes, present polyploidy (more than one set of 
chromosomes)136, although this event is generally rare in mammals. Polyploidy normally 
derives from cell to cell fusion events, although it has been stated that this phenomenon might 
also occur during physiological and pathological conditions either in response to aging (e.g. 
cell senescence) or to stress (e.g. oxidative and mechanical insults)136. If one assumes that 
cardiomyocytes are polyploid then, the mononucleated fraction identified in the previous 
section must present only one set of chromosomes, in order to suggest that these cells do not 
originate from cell fusion events but rather come from precursor cells able to differentiate into 
this cell type. In order to examine the polyploidy of their nuclei, cardiomyocytes were isolated 
from 2 month old Sca1-tTA//LC1-Cre//Z/AP male mice. Using FISH (Fluorescence in situ 
hybridization) against the Y chromosome, cardiomyocytes were counted based on the number 
of nuclei and their Y chromosome. As shown in Figure 20, 18.88±2.97% of isolated AP+-
cardiomyocytes contained one nucleus with one Y-chromosome, while 8.06% of all 
mononucleated cells were AP+. 73.50% contained more than one nucleus but still had only 
one Y-chromosome per nucleus (68.28±14.27, 3.55±6.60 and 1.67±1.67 for 2, 3 and 4 nuclei, 
respectively) and 7.83±5.65% contained two nuclei with more than one Y-chromosome in at 
least one nucleus. These data are comparable to the number of cardiomyocytes found in the 
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AP-negative fraction. In this case, 25.60±6.02% had one nucleus and one Y-chromosome and 
71.98% had more than one nucleus but one Y-chromosome per nucleus (64.38±7.85, 
3.62±2.11 and 3.98±2.30 for 2, 3 and 4 nuclei, respectively). Furthermore, the AP-negative 
fraction revealed a slight decrease in the number of cardiomyocytes with two nuclei but more 
than one Y-chromosome in at least one nucleus (2.41±1.67%). In general, in both the AP+ 
(derived from Sca1 progenitor cells) and AP- cardiomyocytes, it was possible to find a similar 
pattern regarding the number of nuclei. Although the majority was constituted by one Y-
chromosome-binucleated cardiomyocytes, still a percentage of one Y-chromosome-
mononucleated cardiomyocytes was detected. These data highlight that, cardiomyocytes with 
one nucleus and only one Y-chromosome could not derive from cell fusion events, but rather 
are newly generated. In the case of the AP+-cardiomyocytes, the one Y-chromosome-
mononucleated fraction possibly represents the outcome of Sca1-derived cardiac 
stem/progenitor cells (CSCs) differentiation. 
 
 
Figure 20. Cardiomyocyte regeneration and polyploidy.  
Adult cardiomyocytes were isolated from 2 month old Sca1-tTA//LC1-Cre//Z/AP male mice. After overnight 
culture, FISH was performed using Y-chromosome probe (in red), in combination with AP (anti-hPLAP 
antibody in green) and nuclei were counterstained with DAPI (blue). (a) Representative graphs and relative table 
evaluating the number of nuclei and presence of Y chromosome in the AP+ and AP-negative cardiomyocytes 
fractions. (b) Examples of binucleated AP+-cardiomyocytes with different numbers of Y-chromosomes. (c) An 
example of mononucletated AP+-cardiomyocyte (green) with one Y-chromosome red, DAPI (in blue) (left 
picture) and stained also with Phalloidin-633 (in gray) (right picture). 
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6.1.5 CSCs are located beneath the basal lamina suggesting the presence of a 
niche in the heart 
 
During the experiments performed in section 6.1.4, the presence of small, round shape cells 
attached to cardiomyocytes was observed. Although a strong dissociation method was used, it 
seemed that these small cells were tightly attached to isolated cardiomyocytes. In order to 
characterize these cells and to understand whether they belong to a Sca1 subpopulation of 
cells, immunostaining with an antibody against SCA1 was performed.  
Only these small round cells were positive for SCA1 surface marker, whereas cardiomyocytes 
never showed expression of this marker (Figure 21b). To confirm this observation, 
cardiomyocytes were isolated from Sca1-GFP mice. In this mouse strain the GFP expression 
is under the control of Sca1 promoter, therefore each cell presenting an active Sca1 promoter 
will be GFP positive. As shown in Figure 21a, small, round shaped GFP+-cells were observed 
right next to the isolated cardiomyocytes. A quantitative analysis revealed that 8.55% 
cardiomyocytes owned an attached SCA1+-cell. To identify the structural position of the 
above identified small cells, laminin immunostaining was performed (Figure 21c). The co-
staining of SCA1 together with laminin revealed the possible location beneath the basal 
lamina, which resembles the location of skeletal progenitor muscle cells called “satellite 
cells”41. This result highlights the possible presence of a niche where Sca1-expressing cells 
are confined. 
 
Figure 21. Possible niche of CSCs.  
(a), (b) Adult cardiomyocytes were isolated from Sca1-GFP and wild type (C57BL/6) mice. The presence of 
small, round shaped cells attached to the cardiomyocytes was clearly visible. Immunofluorescence staining was 
performed for GFP (in green), SCA1 (in red), phalloidin (in grey) and nuclei were counterstained with DAPI (in 
blue). (c) Laminin staining (in green) was performed to check the position of Sca1-positive cells (in red) attached 
to the cardiomyocytes in wild type mice.  
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6.1.6 Sca1+-cell are a heterogeneous population in the heart 
 
Although Sca1-derived cells in the heart seem to give rise to all the three major lineages as 
shown in the previous section (6.1.1), it is not clear whether these cells derive either from a 
common progenitor cell or from various cell populations expressing Sca1. To address this, 
Sca1-tTA//LC1-Cre mice were crossed with R26R-Confetti reporter line105. This mouse 
consists of a floxed neomycin resistance roadblock fused with the floxed Brainbow 2.1 
construct104 and is inserted into the Rosa26 locus under the CAAG promoter. The Brainbow 
2.1 construct encodes four different fluorescent reporter proteins flanked by variant loxP sites: 
mCFP (blue), nGFP (green), YFP (yellow) and RFP (red). Upon Cre expression, the loxP 
sites recombine, the roadblock cassette will be removed and randomly one of the four 
fluorescence proteins will be located under the control of the CAAG promoter and therefore 
expressed. As a consequence, if the cells are derived from the same progenitor it will be 
labeled by only one color. The presence of cells with different colors will indicate the 
heterogeneity of cell populations and the existence of cell clones with different origins. In the 
case of Sca1-tTA//LC1-Cre//R26R-Confetti mice, the expression of Cre is under the control of 
the Sca1 promoter and whenever a cell expresses Sca1, it will be labeled with one of the 4 
fluorescence proteins. In this mouse, the presence of cells with different colors is a sign of the 
presence of distinct clone population of Sca1-derived cells. As shown in Figure 22a, a random 
activation of specific fluorescent reporter protein in different areas of the myocardium was 
observed in the heart of 2 months old Sca1-tTA//LC1-Cre//R26R-Confetti mice. 
Immunofluorescence stainings with Phalloidin-633 and alpha smooth muscle actin-FITC were 
performed to characterize the cell type of the labeled cells. The staining revealed the presence 
of labeled Sca1-derived cardiomyocytes and smooth muscle cells (Figure 22b & c). All the 
four colors were detected in the heart section indicating that Sca1-derived cells are composed 
of different cells populations. Furthermore, it was possible to find in a precise area cells 
belonging to the same lineage having different colors (e.g. cardiomyocytes either in red, or 
yellow, or blue). Due to the fact that each color represents a different Sca1-derived cell clone, 
a possible conclusion is that the color is not specific for a certain lineage (e.g. the red clone 
gives rise only to cardiomyocytes). In this regard, the color variety of the differentiated cells 
(e.g. cardiomyocytes and smooth muscle cells) reflects the capacity of each clone to give rise 
to different lineages (Figure 22d). Furthermore, the colors distribution was evaluated in 10 
random areas of heart sections derived from three different mice. This quantitative analysis 
revealed that there is an unequal distribution of the four fluorescence proteins among all 
marked cells, cardiomyocytes and non-cardiomyocytes (Figure 22e). These data indicate that 
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Sca1-derived cells represent a highly heterogeneous population able to give rise to both non-
cardiomyocytes (such as smooth muscle cells) and cardiomyocytes but not in equal number 
and fixed proportion. 
 
Figure 22. Heterogeneity of Sca1-derived progenitor cells in vivo.  
Representative images of Sca1-tTA//LC1-Cre//R26R-Confetti mice heart (2 months old). In this mouse model, 
the expression of Sca1 will lead to Cre-loxP recombination with consequent random activation of one out of the 
four fluorescent reporter proteins (GFP, YFP, RFP and CFP). Each color represents a different clone coming 
from Sca1 progenitor cells. The presence of different colors indicates the cellular heterogeneity of Sca1-derived 
population. (a) Cells belonging to the same lineage but with different colors were detected in the same area. (b & 
d) Sca1-derived cardiomyocytes with different colors were detected by phalloidin staining. (c) A representative 
image of blood vessels with cells with different colors identified by an antibody against alpha smooth muscle 
actin (green). (e) A multilevel pie chart summarizing the counting of cardiomyocytes and non-cardiomyocytes 
cells in ten different regions of different heart sections.  
 
6.1.7 Molecular analyses of the Sca1+-cells population 
 
The results obtained from Sca1-tTA//LC1-Cre//R26R-Confetti mice suggest the existence of 
heterogeneity in Sca1 progenitor cells. This heterogeneity could indeed reflect differences at 
the transcriptional level of the Sca1-derived cells´ subpopulations. To investigate this, 
microarray analyses were performed to characterize the transcription profile of Sca1-
expressing cells. CSCs were isolated using Millipore kit (as described in section 5.2.2). The 
kit guarantees an enrichment of SCA1+-cells with a purity of 33 to 50%. After isolation, total 
RNA extracted from CSCs was hybridized to Affymetrix gene arrays. Comparison to gene 
array data sets from other cell types including ES cells, mesenchymal stem cells, endothelial 
cells, cardiomyocytes and different types of fibroblastoid cells, revealed that the 
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transcriptional profile of CSCs is more similar to adult cardiac fibroblasts than any other cell 
type analyzed (Figure 23a). Recently, Ieda et al.125 have shown that the concomitant 
expression of three different cardiac developmental transcriptional factors (Gata4, Mef2c, and 
Tbx5), can efficiently reprogram cardiac fibroblasts into differentiated cardiomyocyte-like 
cells which show a gene expression profile similar to neonatal cardiomyocytes. The similar 
transcription profile between Sca1+-enriched CSCs and cardiac fibroblasts could support the 
hypothesis that CSCs give rise to cardiomyocytes. CSCs however represent a mixed 
population and the transcriptomic profile was not specific for a pure population of Sca1+-
cells. Therefore, the second step was to focus on SCA1-expressing cells to obtain a specific 
gene profile of this cell population. From the total heart, individual SCA1+CD31-CD45- CSCs 
were isolated by FACS (Figure 23b) and single cell real-time RT-PCR was performed on 
Dynamic ArraysTM using the BioMark HD system (Fluidigm Inc.). The primers used were 
designed against 263 coding mRNAs and one non-coding RNA (ncRNA) (Airn), which were 
chosen on the basis of their expression in different stem cell types as well as during cardiac 
development. Samples with no Ct value for endogenous control genes (Actb and Gapdh) and 
with high variation in Ct values among three independent measurements of Actb for each 
sample were excluded from further analysis. As a result, 74 samples were selected for further 
analyses. The gene values were then normalized to the endogenous control by subtracting the 
Actb expression level to derive geometric means on a linear scale128. Furthermore, genes with 
Ct value detected less than in 7 cells were excluded from analysis. The remaining 103 genes 
were used to create the array matrix together with the 74 SCA1+CD31-CD45- single cells. 
Furthermore, the expression of each gene in SCA1+CD31-CD45- cells was compared to other 
cells such as ES118, P19CL6 127 and unsorted CSCs, used as internal positive controls.  
From these analyses, more than 80% of individual SCA1+CD31-CD45- CSCs expressed Sirt7, 
Stat5a, Stat2, Nestin, Lin28a, Hes3, CD79a, Axin1, Il1r1, Crabp2 and Pdgfrbeta, while the 
remaining genes were expressed in smaller subsets of cells. For further characterization, the 
expression profile of each gene in single SCA1+CD31-CD45- cells was compared to each 
other and grouped using R package clValid, system containing different methods to validate 
the results obtained from cluster analyses. The resulting outcome was the presence of two 
large subpopulations inside SCA1+CD31-CD45-, one expressing Nestin and Stat2, and the 
other negative for these genes (Figure 23c). The quality of the sorting was validated by 
immunofluorescence staining. Typical stemness and cardiac progenitor cell markers were 
chosen, such as ABCG2, GATA4, NANOG, OCT4 and SOX2 to confirm the accuracy of the 
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sorting (Figure 23d). Expression of ABCG2 was observed in 21.98%, of GATA4 in 16.67%, 
of NANOG in 0.88%, of OCT4 in 9.58%, and of SOX2 in 25.36% of all analyzed cells.  
 
Figure 23. Single cells analyses of SCA1-expressing cells and transcriptional profile analyses.  
CSC SCA1+-cells were compared with total heart fraction, ES cells, fibroblast, mesenchymal cells and 
endothelial cells. (a) Heat map of the CSCs transcriptional profiles was created using MultiExperiment Viewer 
(MeV). The higher expression of a gene is indicated in red, a lower expression in green. The CSCs 
transcriptomic profile was clustered together with data derived from the positive controls (cardiac fibroblasts, 
MASC, ES, etc.). The hierarchical tree map shows how CSCs (in red), are close to cardiac fibroblasts. (b) FACS 
strategy used to sort single SCA1+CD31-CD45- CSCs. First the isolated cells were selected on the basis of 
forward and side scatter. In the first plot the gate indicates the cardiac stem cell population selected. In the 
second plot are indicated the cardiac stem cells negative for CD31 and CD45 (gate bottom left). From these 
cardiac stem cells, the cells positive for SCA1 were then selected (third plot, gate in the right side). In total the 
percentage of the cells SCA1+CD31-CD45- were 0.78%.(c) Representative heat map of SCA1+CD31-CD45- 
CSCs single cells, emphasizing the expression of certain genes (e.g. Nestin, Stat2 and Tgfb3) able to mark a 
division inside this population. Each column represents a single cell and each line a specific gene. The brighter 
shade of red indicates the high expression of the gene in that particular cell. (d) Representative images of 
cytospin, SCA1+CD31-CD45- CSCs stained with OCT4, SOX2 and ABCG2 antibodies. The percentage of 
positive CSCs is shown in the table. 
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6.2 Identification and analyses of resident cell populations in the 
skeletal muscle and their contribution to muscle regeneration  
 
6.2.1 Sca1 progenitor cells contribute to myofiber formation during aging and 
after injury 
 
The results obtained in the lineage tracing experiments, lead to the conclusion that these 
resident stem cells constitute a source of resident stem cells in the heart. Due to these 
observations, it was speculated that Sca1-progenitor cells could also play a role in the 
maintenance and regeneration of the skeletal muscle. Sca1-tTA//LC1-Cre//Z/AP mouse strain 
was used to address these questions. This mouse represents a perfect model to trace the fate of 
Sca1-derived cells and to reveal the ability of these cells to be committed to myogenic 
lineage. Furthermore, these investigations could help to answer whether, beside the well 
characterized unipotent skeletal muscle resident stem cells (satellite cells), other sources of 
progenitor cells exist and contribute to muscle regeneration. Two different conditions were 
considered in this study to observe Sca1-derived cells behavior in skeletal muscle tissue: 
aging and muscle regeneration. Aging and the consequent accumulation of fibrotic tissue are 
known to affect the ability of resident stem cells to differentiate and generate myofibers137. 
Mice at the ages of 3, 6, 18 and 24 months were chosen to determine if Sca1 progenitor cells 
are involved in myofiber formation and whether aging could affect their contribution. These 
ages are used in the literature to define young, adult, old and very old mice respectively137. 
Cardiotoxin injections were performed which well characterized model for studying muscle 
regeneration. Cardiotoxin is a snake venom able to disrupt the plasma membrane of muscle 
cells leading to myonecrosis138. The damage induces the activation of resident stem cells and 
leads to their differentiation and subsequent formation of new myofibers139-141. In this study, 
the general procedure was to inject the cardiotoxin in the left leg (left anterior tibialis muscle 
“TAL”) and leave the right one (right anterior tibialis muscle “TAR”) uninjured. The TAR 
was used as negative control. Following this scheme one mouse was suitable for following the 
behavior of Sca1-derived cells both during aging (considering the TAR) and during muscle 
regeneration (considering the TAL).  
Immunofluorescence staining against human placental alkaline phosphatase (AP antibody) in 
combination with anti-laminin antibody was performed in muscle sections to verify the 
presence of Sca1-derived cells. As shown in Figure 24c some AP+-cells seemed to be located 
underneath the basal lamina, which is the typical localization of satellite cells41. Furthermore, 
the presence of AP+-muscle fibers was observed in tissue sections, suggesting a possible 
contribution of Sca1-precursor cells to muscle fiber formation (Figure 24a & e). The number 
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of AP+-fibers was normalized to the total number of fibers presents in an anterior tibialis 
muscle115 and the percentage of fibers was derived in order to detect substantial changes in the 
numbers during aging and regeneration. It was possible to observe a decrease in the number 
of AP+-fibers in 3 to 18 month old mice, confirming that aging affects the ability of Sca1-
derived cells to give rise to myofibers (3 month old mice: 0.21±0.00% in TAR; in 6 month old 
mice: 0.10±0.01% in TAR; in 18 month old mice: 0.05±0.01% in TAR). Concerning muscle 
regeneration, the preliminary experiment involving only one cardiotoxin injection revealed 
that one injury was not sufficient to promote the differentiation of Sca1-derived cells. In fact 
the number of AP+-fiber was not significantly affected as compared to the contralateral 
muscle (Figure 24a&b). In this respect, it was speculated that repeated damage could better 
stimulate Sca1-derived cells enhancing their participation in muscle regeneration (Figure 24 b 
& f). Upon three cardiotoxin injections, a slight decrease in the numbers of AP+-cells was 
observed in young and very old mice (in 3 month old mice: 5.37±0.04 cells/mm2 in TAR and 
4.85±0.03 cells/mm2 in TAL; in 24 month old mice: 4.80±0.25 cells/mm2 in TAR and 
2.91±0.13 in cells/mm2 TAL) whereas an increase was recorded in adults and old animals (in 
6 month old mice: 11.24±0.17 cells/mm2 in TAR and 12.58±0.21 cells/mm2 in TAL; 18 
month old mice: 5.14±0.49 cells/mm2 in TAR and 25.20±0.51 cells/mm2 in TAL) (Figure 
24d). However, the fluctuations in the number of AP+-cells do not directly reflect the number 
of AP+-fibers and consequently the potential of Sca1-derived cells to contribute to muscle 
regeneration. Statistically significant increases in the percentage of AP+-fibers was recorded 
for young and middle aged mice upon injuries (in 3 month old mice: 0.21±0.00% in TAR and 
0.45±0.02% in TAL; in 6 month old mice: 0.10±0.01% in TAR and 0.35±0.04% in TAL) no 
difference was observed in old age (in 18 month old mice: 0.05±0.01% in TAR and 
0.06±0.02% in TAL) (Figure 24f). Furthermore, in very old mice the contribution of Sca1-
derived cells in muscle regeneration was lower as suggested by the diminished number of 
AP+-fibers in the injected muscle as compared to the control (in 24 month old mice: 
0.13±0.01% in TAR and 0.07±0.01% in TAL) (Figure 24f).  
These data suggest that aging can affect the ability of Sca1-derived cells to be involved in 
myofiber formation and multiple damage can increase their stimulation and participation to 
muscle regeneration. 
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Figure 24. Contribution of Sca1 progenitor cells to muscle fibers formation during aging and muscle 
regeneration in the Sca1-tTA//LC1-Cre//Z/AP mouse model. 
Sca1-tTA//LC1-Cre//Z/AP mouse was used to lineage trace Sca1 progenitor cells in skeletal muscle in vivo. The 
mice were injected each month with cardiotoxin (a total period of three months) to induce muscle regeneration. 
The presence of AP+-cells (stained with anti-hPLAP antibody) and AP+-fibers was detected. Different mouse 
ages were considered: 3, 6, 18 and 24 months old. (a) Representative image of cross-section of the anterior 
tibialis muscle injured only one time with cardiotoxin showing one AP+-fiber. (b) Quantification of the number 
of AP+-fiber after a single cardiotoxin injection. (c) Representative image of cross-section of the anterior tibialis 
muscle (injured) showing the presence of AP+-cells presumably located under the basal lamina similarly to 
satellite cells. (d) Quantification of the number of AP+-cells/mm2 in mice at different ages. (e) Representative 
image of cross-section of the anterior tibialis muscle (injured) showing the presence of AP+-fibers. (f) 
Quantification of the number of AP+-fibers during aging. In all the graphs the grey bar represents the not injured 
muscle, whereas the white bar represents the injected muscle. 
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6.2.2 Sca1 progenitors cells contribute to the formation of myofibers in a model 
of Duchenne muscular dystrophy 
 
To understand if Sca1 progenitor cells are able to contribute to muscle regeneration in 
pathological conditions, the triple transgenic mouse system described above (Sca1-tTA//LC1-
Cre//Z/AP) was crossed with the mdx mouse line, which represents a model for Duchenne 
muscular dystrophy110 (Figure 25a). 
In order to observe the contribution of Sca1 progenitor cells, 3 and 6 months old Sca1-
tTA//LC1-Cre//Z/AP//mdx(-/-) mice were injected with cardiotoxin as previously described in 
section 6.2.1. One injection per month was performed for a total period of three months. As 
shown in Figure 25c, the quantification of the number of AP+-cells was higher in the injured 
muscle (TAL) compared to the control (TAR) in both ages considered (in 3 month old mice: 
13.34±0.59 cells/mm2 in TAR and 24.06±0.55 in TAL; in 6 month old mice: 17.64±0.68 in 
TAR and 27.26±1.13 in TAL). Furthermore, when the percentage of AP+-fibers was 
examined in 3 month old mice, an increased number of AP+-fibers was observed in the 
injured muscle compared to the control (0.11±0.0034% in TAR and 0.18±0.0037% in TAL) 
(Figure 25e). However, in contrast to the analysis of Sca1-tTA//LC1-Cre//Z/AP mice (section 
6.2.1), a decrease in the percentage of AP+-fibers was observed upon injuries in 6 months old 
mice (0.15±0.0033% in TAR and 0.10±0.0019% in TAL). The presence of AP+-fibers in 
Sca1-tTA//LC1-Cre//Z/AP//mdx(-/-) confirm a role for Sca1 progenitor cells in contributing to 
muscle regeneration under pathological conditions. This contribution is higher in young 
animals compared to old ones. However, although the diminished number of AP+-fibers in 6 
month old mice after 3 cardiotoxin injections, it was still possible to find newly formed AP+-
fibers as indicated by the central position of the nucleus, where usually in pre-existing 
myofibers the nuclei are located in the periphery142. 





6.2.3 Sca1 progenitors cells could differentiate into muscle tissue following 
different pathways 
 
The results from sections 6.2.1 and 6.2.2 strongly suggest that Sca1 progenitor cells can 
contribute to muscle regeneration during aging, upon injury, and under pathological 
conditions. Myogenic cell differentiation has been described as being regulated by specific 
myogenic factors such as Pax7, MyoD, Myf5, MRF4 and Myogenin143. Pax7, transcription 
factor,  is known to be a marker for satellite cells and it is expressed during the earlier stages 
of myogenic commitment143. Even if it was observed that Sca1 progenitor cells give rise to 
myogenic fibers, it still remains unclear whether they follow the “canonical” myogenic 
expression pathway or not. In order to elucidate if Sca1 progenitor cells require the expression 
of Pax7 to be active and differentiate, Sca1-tTA//LC1-Cre//Z/AP mice were crossed with 
conditional Pax7 mice (Pax7loxPGu/loxPGu). In the Pax7loxPGu/loxPGu mice the DNA binding 
domain of Pax7 is flanked by loxP-sites111 (Figure 26a). In Sca1-tTA//LC1-
Figure 25. Contribution of Sca1 
progenitor cells after ijury in mdx 
mice.  
(a) Sca1-tTA//LC1-Cre//Z/AP mice 
were crossed with “mdx” mice, a 
mouse model of Duchenne muscular 
dystrophy. For the injury model, the 
same scheme described in section 
6.2.1 was used and two different age 
groups were considered: 3 and 6 
months old. (b) Representative image 
of cross-section of the anterior tibialis 
muscle (injured) showing the presence 
of AP+-cells. (c) Quantification of the 
number of AP+-cells/mm2 under 
pathological condition.  
(d) Representative image of cross-
section of the anterior tibialis muscle 
(injured) showing the presence of 
center nucleated AP+-fiber, indication 
of newly regenerated fiber.  
(e) Quantification of the number of 
AP+-fibers under pathological 
condition. In the graphs the grey bar 
represents the not injured muscle, 
whereas the white bar represents the 
injected muscle. 
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Cre//Z/AP//Pax7loxPGu/loxPGu mice, the expression of Sca1 leads to the expression of Cre-
recombinase present in the LC1-Cre allele. The Cre-recombinase recombines the loxP of 
Pax7 allele with consequent excision of exon I-III of Pax7 gene inactivating its expression. 
The same Cre-recombinase will also excise the lacZ-stop cassette present in the Z/AP reporter 
line, mediating the expression of alkaline phosphatase instead of lacZ. In this mouse model, 
the cells that express Sca1 at least once in their life will be positive for alkaline phosphatase 
(AP) and will not express a functional Pax7, whereas cells that will express Pax7 (e.g. 
satellite cells) will not be labeled and consequently not traced. The presence of AP+-fibers in 
3 and 6 month old Sca1-tTA//LC1-Cre//Z/AP//Pax7loxPGu/loxPGu mice under physiological 
conditions and after injury (i.e. cardiotoxin injection), confirmed the presence of a 
subpopulation of Sca1+-cells able to contribute to myofiber formation without the expression 
of Pax7 (Figure 26b). This subpopulation seems to be more active in muscle regeneration in 
younger mice, as indicated by the increased number of AP+-fibers in 3 months old mice as 
compared to 6 month old animals (in 3 month old mice: 0.08±0.0053% in TAR and 
0.26±0.16% in TAL; in 6 month old mice: 0.13±0.0038% in TAR and 0.04±0.0021% in TAL) 
(Figure 26c). This discrepancy might be due to some crucial transcription factors that are 
normally present during young stages whereas in the adult they are not significantly 
expressed. This idea is supported by the data already described in literature concerning the 
difference between embryonic and adult myogenesis144. In particular, Lepper et al. 
demonstrated that Pax7 expression is crucial during myogenic commitment up to twenty-one 
days after birth (P21). Using a tamoxifen-inducible mouse model to lineage trace Pax7-
expressing cells (Pax7(CE))144, they were able to show that 21 days after birth, adult satellite 
cells do not need the expression of Pax7 to differentiate into myofibers.  
Based on these results and due to the fact that the subpopulation of Sca1 progenitor cells not 
expressing Pax7 are more active in muscle regeneration in younger mice, Sca1-tTA//LC1-
Cre//Z/AP//Pax7loxPGu/loxPGu mice were used to observe whether the involvement of these cells 
might be pronounced in younger mice. The tibialis anterior muscles from 17 day old pups 
(P17) were examined and the presence of AP+-fibers was identified under normal 
physiological conditions both in longitudinal and cross sections (Figure 27). In order to check 
if muscle injury could activate this Sca1+ subpopulation during earlier stage, cardiotoxin was 
injected in the anterior tibialis muscle of 14 day old pups (P14) and the pups were sacrificed 
at 21 days after birth (P21). Both anterior tibialis muscles (injected and control) were 
collected and alkaline phosphatase staining was performed. The higher number of AP+-fibers 
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in the section suggested an increased contribution of the subpopulation of Sca1 progenitor 
cells not expressing Pax7 at the earlier stages after damage (Figure 27).  
These data suggest that a subpopulation of Sca1 progenitor cells does not seem to need the 
expression of Pax7 to participate in muscle regeneration. Furthermore the contribution of this 
population is almost negligible at young and adult stages during physiological conditions, 
whereas their involvement increases after injury and even more at earlier stages as before P21.  
 
Figure 26. Presence of a subpopulation of Sca1 progenitor cells in skeletal muscle involved in myogenesis 
independently from Pax7 expression.  
(a) Sca1-tTA//LC1-Cre//Z/AP//Pax7loxPGu/loxPGu mouse model scheme. In this mouse model, the expression of 
Sca1 activates tTA and transcribes for Cre-recombinase. Cre-recombinase allows the expression of alkaline 
phosphatase in Z/AP mouse and at the same time excises exon 1, 2 and 3 from Pax7 floxed gene. (b) 
Representative images of cross sections of left anterior tibialis muscle of 3 months old mice before and after 
damage induced by cardiotoxin injection. (c) Quantification of the number of AP+-fibers. Three month old mice 
show an increased number of AP+-fibers in response to cardiotoxin injection, whereas in 6 month old mice the 
number is reduced. In the graph the grey bar represents the not injured muscle, whereas the white bar represents 
the injected muscle. 




6.2.4 In vivo Sca1 progenitor cells seem to be multipotent stem cells whereas 
satellite cells are unipotent  
Although Sca1 progenitor cells could give rise to a certain number of myofibers during aging 
and pathological conditions, satellite cells remain the major stem cell source for myogenesis. 
Discovered in 1961, satellite cells are muscle precursor cells that can replenish muscle fibers 
upon damage41. A small percentage (~10%) of these cells possess stem cell-like functions and 
can expand the pool of resident satellite cells maintaining muscle homeostasis145. The 
potential to easily isolate and culture satellite cells, has increased their use in vitro as a model 
for myogenic differentiation. However, although 50 years have passed since the discovery of 
satellite cells, the factors that are important in maintaining the stemness of these cells as well 
as the signaling pathways involved in the control of their proliferation and differentiation still 
remain poorly understood146. It was demonstrated that satellite cells can differentiate into 
adipocytes and osteoblasts both in vitro147,148 and ex vivo149,57, but it is still not clear whether 
such differentiation capabilities are retained in vivo. In order to address this question the 
Figure 27. Presence of a 
subpopulation of Sca1 progenitor 
cells that do not express Pax7 
and are involved in myogenesis 
during early postnatal stages.  
Contribution of Sca1 progenitor 
cells not expressing Pax7 during 
earlier stages. (a & b) 
Representative pictures of 
transverse and cross section of 
tibialis anterior muscle in P17 
mice. Presence of AP+-fibers was 
detected. (c) Representative images 
of control and injected anterior 
tibialis muscle at P21. (d) 
Representative image at higher 
magnification showing the 
presence of AP+-fibers after 
injection. (e) Quantification of the 
number of AP+-fibers showing 
their increase in response to 
cardiotoxin injection in P21 mice. 
In the graph the grey bar represents 
the not injured muscle, whereas the 
white bar represents the injected 
muscle.
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transgenic mouse Pax7-Cre109 was crossed with a reporter Z/AP mouse line101 to examine 
whether satellite cells are unipotent stem cells in vivo. In the double transgenic mouse model 
Pax7-Cre//Z/AP, upon expression of the nuclear transcription factor Pax7 Cre-recombinase is 
transcribed. The Cre-recombinase recombines the loxP sites of the lacZ-stop codon cassette 
present in the Z/AP reporter mouse activating the transcription of alkaline phosphatase instead 
of lacZ gene. In this mouse model a cell expressing Pax7 will be permanently labeled with 
alkaline phosphatase. The Pax7-Cre//Z/AP mice were injected with molecules known to be 
involved in vivo in osteoblast (hBMP4)149and adipocyte formation (hBMP7)150. These 
molecules were injected either separately or in combination. The injection was performed in 
the left anterior tibialis muscle whereas the contralateral (right anterior tibialis muscle) was 
left untreated. The mice were sacrificed one month after the injection and different stainings 
were performed to validate the possible formation of ectopic tissue and the involvement of 
satellite cells in this process. Alkaline phosphatase staining was done in order to detect the 
localization and the contribution of satellite cells after injection. Oil red O, a colorant that 
forms precipitates in the presence of lipid drops, was used to detect the presence of adipocytes 
and triglycerides. Furthermore Alizarin red, a dye that forms orange/red precipitates in the 
presence of calcium, was used to confirm the presence of calcium deposits.  
As shown in Figure 28, compared to the injection with hBMP4 alone, the combination of 
hBMP4/7 showed an increase in Oil Red O stained cells in the injected region as compared to 
the contralateral muscle. A similar trend was observed in the case of Alizarin red staining. All 
AP+-cells were negative for Oil Red O or Alizarin red staining, regardless of the 
administration of hBMP4 and hBMP7 alone or in combination. These results clearly indicate 
that, in vivo, satellite cell differentiation is restricted to myofibers and they cannot 
differentiate in either osteoblasts or adipocytes. It has been speculated that this lack of 
multipotency in vivo in satellite cells could be caused by a crosstalk with other cells65. For 
instance, specific cells such as FAPs, fibro/adipocyte progenitor cells, able in vivo to give rise 
to adipocytes and fibroblasts, could balance satellite cell commitment towards a certain 
lineage rather than another63,64. For instance it has been shown that FAPs, by releasing 
specific interleukins (e.g. IL6), could promote in vivo the differentiation of satellite cells into 
myogenic lineage and suppress their ability to differentiate in other cell types65. These FAPs 
are indeed described to also express Sca164. In order to understand if the population of Sca1 
progenitor cells identified in this study shows a multipotent phenotype, the triple transgenic 
mouse model Sca1-tTA//LC1-Cre//Z/AP mouse was again considered (described above in 
sections 5.1.1 & 6.1.1). Additionally the left tibialis anterior muscle of these mice was 
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injected with the same set of BMP molecules described above. As shown in Figure 29, 
alkaline phosphatase staining in combination with Oil red O and Alizarin red revealed the 
presence of Sca1-derived cells in the region of the ectopic tissue formation. These results, 
indicate the commitment of these cells and their contribution to the ectopic bone and adipose 
tissue formation, revealing the capability of Sca1-derived cells to be committed not only 
towards a myogenic lineage but also towards the other mesodermal lineages, contrarily to 
satellite cells. 
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Figure 28. Injections of BMP molecules in Pax7-Cre//Z/AP mice.  
The muscle anterior tibialis of Pax7-Cre//Z/AP mice was injected with different BMP molecules in order to 
promote the formation of ectopic bone and adipose tissue. Sections of the injected muscle and relative controls 
were stained with alkaline phosphatase, Oil red O (adipocytes) and Alizarin red (osteoblasts). The absence of 
alkaline phosphatase positive cells in the region of ectopic formation indicates that satellite cells are not able to 
differentiate in either adipocytes or osteoblasts. 
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Figure 29. Injections of BMP molecules in Sca1-tTA//LC1-Cre//Z/AP mice.  
The muscle anterior tibialis of Sca1-tTA//LC1-Cre//Z/AP mice were injected with BMP molecules. Different 
stainings for alkaline phosphatase, Oil red O (adipocytes) and Alizarin red (osteoblasts) were performed to detect 
the formation of ectopic tissue in the anterior tibialis muscles of the mice. Sca1-derived cells are involved and 
participate in the formation of adipocytes and osteoblasts as confirmed by the positive staining of alkaline 
phosphatase in the ectopic region.  
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6.2.5 Sca1 progenitors cells could contribute to adipocytes formation in vivo 
The above results strongly support the idea that Sca1-derived cells might contribute to the 
formation of adipocytes and osteoblasts upon injection of BMP molecules. The ability of Sca1 
progenitor cells to form adipocytes in vivo was further demonstrated by performing glycerol 
injection. The glycerol injection model has been reported to induce myogenic cell death by 
disrupting the cytoplasmic membrane with consequent substitution of muscle tissue with 
adipose tissue63. One source of this lipid formation seems to be FAPs (fibro-adipocyte 
progenitor cell positive for PDGFRalpha and SCA1)63. Therefore the left tibialis anterior 
muscle of Sca1-tTA//LC1-Cre//Z/AP mice was injured with glycerol, whereas the right 
tibialis anterior muscle was used as a negative control. Oil red O staining was performed to 
reveal the formation of adipocytes. Large lipid drops were detected throughout all the muscle 
sections (Figure 30a & b). Furthermore, to identify Sca1-derived cells, immunofluorescence 
staining was performed. Human placental alkaline phosphatase antibody (AP) was used in 
combination with PERILIPIN, a marker for adipocytes. As shown in Figure 30c, PERILIPIN+ 
adipocytes are also positive for AP, confirming that Sca1 progenitor cells are involved in 
adipocyte formation.  
 
Figure 30. Formation of adipocytes in vivo.  
Glycerol was injected in tibialis anterior muscle of Sca1-tTA//LC1-Cre//Z/AP mice to promote the formation of 
adipocytes. (a) Representative picture of Oil red O staining of the cross section of tibialis anterior muscle. (b) 
Higher magnification of lipid formation after glycerol injection in two different areas of anterior tibialis muscle. 
(c) Immunofluorescence staining using anti-PERILIPIN (for adipocytes, in red) and anti-hPLAP (AP+-cells, in 
green) antibodies. Nuclei were counterstained with DAPI (in blue). The lower image shows cells double positive 
for AP and PERILIPIN, confirming the presence of Sca1-derived adipocytes (white arrows). 
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6.2.6 Microarray Analyses of Satellite cells, FAPs and Sca1-expressing  
progenitor cells 
 
Sca1 progenitor cells traced in this study seem to contribute to all the mesodermal lineages 
(myogenic, adipogenic, osteogenic) as described in the previous sections. They are able to 
form myofibers and adipocytes in vivo in a similar manner to satellite cells and FAPs 
respectively. This could be probably due to a common gene expression profile between Sca1-
expressing cells/satellite cells and Sca1-expressing cells/FAPs. In order to confirm this 
hypothesis, microarray analyses were performed using GeneChip® Mouse Exon 1.0 ST Array 
(exon arrays) from Affymetrix, Inc., to determine the gene profile of these populations and to 
provide a better characterization of these cells (Figure 31).  
The following populations of cells were isolated by FACS using specific surface markers: 
 Satellite cells: SM/C-2.6+CD31-CD45-SCA1-151; 
 FAPs: PDGFRalpha+CD31-CD45-63,152; 
 Sca1-expressing cells: SCA1+CD31-CD45-SM/C-2.6-. 
SM/C-2.6 is an antibody developed by Fukada and colleagues153 to isolate quiescent satellite 
cells. PDGFRalpha was used as a marker for FAPs63,152. In all three populations, the cells 
were gated to be negative for CD31 (endothelial marker) and CD45 (hematopoietic marker). 
Furthermore, the three populations were analyzed under two conditions: quiescence 
(physiological condition) and activated state. The activation was obtained by cardiotoxin 
injection and cells were collected two days after injury. The microarray data were analyzed 
using “Exon Array Analyzer” (EAA)119. The up-regulation (both in quiescence and activate 
state) of myogenic genes in satellite cells and of fibro-adipogenic genes in FAPs, confirmed 
their specific lineage commitment observed in vivo. The up-regulation of myogenic, 
fibrogenic, adipogenic genes mainly upon activation in Sca1-expressing cells sustained their 
multipotency in vivo. The ability of Sca1-expressing cells to give rise to osteoblasts has been 
shown in the previous sections it was shown that genes known to be involved in osteogenesis 
were indeed up-regulated in Sca1-expressing cells in quiescent state, highlighting their 
intrinsic osteogenic potency. However upon activation, the same genes were down-regulated, 
likely due to the specificity of cardiotoxin damage in activating the myogenic program. These 
data confirm the ability of Sca1-expressing cells in vivo to differentiate towards other 
mesodermal lineages besides the myogenic one (as described in sections 6.2.4 & 6.2.5) and 
cardiotoxin damage seems to activate the myogenic, adipogenic and fibrogenic marker 
expression but does not induce the osteogenic one.  
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Although from the microarray data it was possible to find genes commonly expressed in 
satellite cells and Sca1-expressing cells upon activation (Table 6), two particular genes 
highlighted a clear separation between these two populations: Bmp1 and IL6. These two genes 
are known to be involved in the regulation of muscle growth. Bmp1 (Bone morphogenic 
protein 1, belonging to the tolloid-like metalloproteinases family) has been shown to be 
highly regulated in quiescent satellite cells154. Il6 (Interleukin 6) has been described to be 
involved in satellite cell-mediated muscle hypertrophy and induction of muscle growth155. 
According to these data, Sca1-expressing cells express high level of Bmp1 in the quiescent 
state, whereas upon activation the level of Il6 increases. These genes could be a key to 
understand the regulation of quiescence and activation state of Sca1-expressing cells. The 
high level of Bmp1 in normal physiological conditions could keep these Sca1-expressing cells 
in a quiescent state, which may explain why, although presenting myogenic potential, their 
contribution to myofibers formation in vivo is low compared to satellite cells. 
 
 
Figure 31. Microarray dataset.  
(a) Myogenic array. (b) Fibrogenic array. (c) Adipogenic array. (d) Bmp4, Bmp1, Il6, Acvr1 genes expression 
array 
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Table 6.Genes highly upregulated in the microarray analyses. 
The table summarizes the genes highly up-regulated and commonly express between satellite cells/Sca1+-cells 
and Sca1+-cells/FAPs visualize in the heat maps of the Figure 31. Sca1-expressing cells in quiescence state have 
a profile similar to FAPs and they have a high expression of genes belonging to fibrogenic, adipogenic, 
osteogenic lineages. The activation induced by cardiotoxin injection increases the expression also of genes 
belonging to the myogenic lineage and typical for satellite cells.  
 
6.2.7  Single cell transcriptomic analyses of muscle cell 
The data described in the previous paragraph suggest that Sca1-expressing cells possess a 
certain gene expression identity common to both satellite cells and FAPs. FAPs are positive 
for PDGFRalpha63 but also express SCA164. This could possibly explain the similarity of the 
transcriptomic profile between Sca1-expressing cells and FAPs. Satellite cells are commonly 
defined as a population characterized by the expression of the transcriptional factor Pax7 
although they represent a heterogeneous population composed of cells with different 
biochemical and functional features156. Due to this heterogeneity and the similarity found 
between satellite cells and Sca1-expressing cells at the gene expression level upon cardiotoxin 
injection, it was speculated whether a certain number of satellite cells could possibly express 
Sca1 and this expression could mark a specific subpopulation. In order to investigate the 
cellular heterogeneity of satellite cells and the possible different characteristics of the Sca1+ 
and Sca1- populations, the same markers used for the microarray analyses (section 6.2.6) were 
used as well as SM/C2.6 for sorting as the equivalent marker for satellite cells153 instead of 
Pax7. The following six populations were isolated (Figure 32a):  
 FAPS : PDGFRalpha+SCA1- & PDGFRalpha+SCA1+,  
 Satellite cells: SM/C2.6+SCA1-& SM/C2.6+SCA1+;  
 Sca1-expressing cells: SCA1+PDGFRalpha- & SCA1+SM/C2.6-. 
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All the populations were negatively gated for the expression of CD31 and CD45. Single cells 
were sorted from each population. The transcription level of Sca1 (Ly6a), Pdgfralpha and 
Pax7 genes was tested using RT-qPCR for the single cells of the six populations mentioned 
above to examine the accuracy of the sorting. Only the single cells expressing the markers 
specific for the population they belong to, were chosen for single cell gene expression 
analyses. The single cell gene data profile of the samples was generated using Fluidigm 
Dynamic Arrays technology (BioMarkTM HD System). This technology allows performing 
several distinct single RT-qPCR reactions together, at the same time, using a specific 
microarray chip card.  
From the six different populations, the number of single cells able to pass the quality test and 
suitable for the next analyses resulted to be 182 and was divided as follows: SM-
C2.6+SCA1+CD31-CD45- (32 cells), SM-C2.6+SCA1-CD31-CD45- (32 cells), 
PDGFRalpha+SCA1+CD31-CD45- (31 cells), PDGFRalpha+SCA1-CD31-CD45- (23 cells). 
Two samples were created using all the cells mentioned above together with C2C12 and ES 
cells as internal positive controls (Figure 32b). The samples were analyzed for the expression 
of 288 genes specific for cell signaling (e.g. BMP, Notch, Wnt), cell cycle, chemokines, 
growth factors and stem cell markers. For each sample four different microarrays were 
performed using the primers mentioned above. In order to be able to further analyze the 
microarray data obtained, the beta-actin expression value of the four arrays were compared 
using Pearson correlation. Pearson correlation defines how well different data sets are related 
and the linear relationship existing between them. The Pearson coefficient range is defined to 
be from −1 to 1, where 1 represents a positive linear correlation between the values. As shown 
in Figure 32c, the comparison of the data generated by Fludigm technology presented a 
Pearson coefficient close to 1, confirming that the data obtained from the four arrays had high 
correlation and allowing further analyses.  
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Figure 32. Transcriptomic analyses of different populations of muscle cells. 
(a)Six different populations of cells were isolated from the skeletal muscle: SCA1+PDGFRalpha-; 
SCA1+PDGFRalpha+; PDGFRalpha+SCA1-; SCA1+SM/C2.6-; SCA1+SM/C2.6+; SM/C2.6+SCA1-. 
Representative images of dot plots and FACS gates used to isolate the six populations. (b) Representation of 
single cells of each population plated in 96-well plates. Two samples were created. The first sample contains the 
following cell types: in column number one the positive controls, consisting of 4 wells of 100 C2C12 cells and 4 
wells of 100 ES cells; 32 cells of the SM/C2.6+SCA1- population (satellite cells-Sca1-); 32 cells of the 
SM/C2.6+SCA1+ population (satellite cells-Sca1+); 23 cells of the PDGFRalpha+SCA1- population (FAPs-Sca1-). 
In the second plate: 32 cells of the SM/C2.6-SCA1+ population (Sca1+cells- SM/C2.6-); 32 cells of the 
PDGFRalpha-SCA1+ population (Sca1+cells-PDGFRalpha-); and 31 cells of the PDGFRalpha+SCA1+(FAPs-
Sca1+) population. In both sample plates, the last well was left empty (without sample) as an internal negative 
control (c) Pearson correlations of Ct values of beta-actin across experiments. Pearson correlation defines the 
relation among the different data obtained from the four arrays. A value near one reflects a high correlation. The 
high correlation obtained among the four arrays reflects the accuracy of each assay and allow comparing the 
data.  
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Based on the Fluidigm data, a heatmap was created to visualize the expression variance of the 
genes in single cells belonging to FAPs cells (PDGFRalpha+Sca1- and 
PDGFRalpha+Sca1+populations) and satellite cells (SM/C2.6+Sca1- and SM/C2.6+Sca1+ 
populations) (Figure 33a & 34a). The results were then clustered using the R package clValid 
(as described before in section 5.9.2), in order to group cells presenting the same gene 
expression (Figure 33b & 34b). However, also after the clustering it was not possible to 
visualize a common unique gene profile for FAPs and satellite single cells. Although the cells 
were sorted for the same markers, at a single cell level FAPs and satellite cells reveal a high 
gene expression variance.  
The clustering did not identify any difference in FAPs and satellite cells populations in the 
presence or the absence of Sca1. In order to reveal some distinct features, Student t-Test was 
performed in satellite cells (SM/C2.6+Sca1- population versus SM/C2.6+Sca1+ population) 
and FAPS (PDGFRalpha+Sca1- population versus PDGFRalpha+Sca1+ population). Based on 
the t-Test significance, in absence or presence of Sca1 some genes resulted to be significant 
(Figure 33c & 34c).  
In FAPs not expressing Sca1 (PDGFRalpha+Sca1-), the following genes were highly 
expressed: 
 Bmp1 (Bone morphogenic protein 1), 
 Hey2 (Hairy/enhancer-of-split related with YRPW motif protein 2, also known as 
cardiovascular helix-loop-helix factor 1 (CHF1)), 
 Pdgfbeta (Platelet-derived growth factor subunit beta), 
 Vegfc (Vascular endothelial growth factor C).  
The subpopulation of FAPs expressing Sca1 (PDGFRalpha+Sca1+) was in contrast 
characterized by the expression of: 
 Lmna (Lamin A/C), 
  Il6st (Interleukin 6 signal transducer or gp130, or Oncostatin M receptor),  
 Stat6 (Signal transducer and activator of transcription 6), 
 Bmp4 (Bone morphogenic protein 4). 
Satellite cells (SM/C2.6+SCA1- versus SM/C2.6+SCA1+ population) instead of FAPs present 
a different trend. In the subpopulation of satellite cells expressing Sca1 (SM/C2.6+SCA1+) the 
following genes were higher expressed (Figure 34c): 
 Bmp1 (Bone morphogenic protein 1), 
 Pax7 (Paired box gene 7), 
 Cxcl9 (Chemokine (C-X-C motif) ligand 9), 
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 Eltd1 (EGF, Latrophilin seven transmembrane domain containing 1).  
In the satellite cell fraction not expressing Sca1 (SM/C2.6+SCA1-), other genes were highly 
expressed: 
 Il6st,  
 Hes1 (Hairy and enhancer of split 1 (Drosophila)), 
 Kit (c-kit, CD117, belly spot, steel factor receptor), 
 Numbl (Numb-like). 
Interestingly, as already observed in the microarray data for the Sca1-expressing cell 
population, also in satellite cells respectively in the presence and absence of Sca1, the 
expression of Bmp1 and Il6 was detected. It has been speculated that the presence of Bmp1 in 
Sca1-expressing cells is involved in maintaining their quiescence, whereas the Il6 expression 
promote their myogenic commitment. In this regard the presence of Bmp1 in 
SM/C2.6+SCA1+ population could mark a quiescent subpopulation, probably the actual cells 
able to replenish the stem cell pool after damage. On the other hand, the high level of Il6 in 
satellite cells not expressing Sca1 could reflect their tendency to be more prone to 
differentiation.  
These data demonstrate that at a single cell level it is possible to observe a high heterogeneity 
in both satellite cells and FAPs population. Furthermore, the presence of Sca1 in satellite 
cells seems to mark a subpopulation with higher quiescent characteristics.  
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Figure 33. Profiling of fibro-adipocyte progenitor cells (FAPs).  
PDGFRalpha-SCA1+ and PDGFRalpha+SCA1- were compared. (a) Representative image of a heat map 
highlighting the genes expressed in single cells from PDGFRalpha+Sca1- and PDGFRalpha+Sca1+populations. 
The gene profile data were obtained by Fluidigm single cell RT-qPCR. In the heat map the yellow spots indicate 
a high expression and the blue ones a low expression. (b) A result of hierarchical clustering performed by 
Rpackage clValid in order to group cells presenting the same gene expression in FAPs population. (c) 
Representative graphs of genes significantly up or downregulated in the population not expressing (grey bar) or 
expressing Sca1 (white bar). After performing Student t-Test between PDGFRalpha-SCA1+ and 
PDGFRalpha+SCA1- the following genes resulted to be relevant: Bmp1, Hey2, Pdgfd, Vegfc, Lmna, Il6st, Stat6, 
Bmp4.  




Figure 34. Profiling of satellite cells.  
SM/C2.6-SCA1+ and SM/C.6+SCA1- were compared. (a) Representative image of a heat map highlighting the 
genes expressed in single cells of SM/C2.6-SCA1+ and SM/C.6+SCA1- populations. The gene profile data were 
obtained by Fluidigm single cell RT-qPCR. In the heat map the yellow spotsr indicate a high expression and the 
blue ones a low expression. (b) A result of hierarchical clustering performed by Rpackage clValid in order to 
group cells presenting the same gene expression in satellite cells population. (c) Representative graphs of genes 
significant highly up or down regulated in the population not expressing (grey bar) or expressing Sca1 (white 
bar). After performing Student t-Test between SM/C2.6-SCA1+ and SM/C.6+SCA1- the following genes resulted 
to be relevant: Il6st, Hes1, Kit, Numbl, Bmp1, Pax7, Cxcl9, Eltd1.  
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7 DISCUSSION 
7.1 Evidence of the presence of Sca1-expressing cardiac stem cells 
in the heart 
Heart failure and myocardial infarction are the most common cause of death in the western 
world. Although the human lifespan has increased due to better health care conditions, heart 
failure still affects 2-3% of the adult population and this percentage increases with age 
reaching 20-30% in people older than 70 years157. The raise of heart diseases affects not only 
the medical sphere, but also public welfare. The costs related to the treatment of patients 
affected by heart failure, for instance, have increased exponentially in recent years. Therefore, 
the need to prevent and cure heart disease has acquired a great importance, not only for the 
amelioration of health care conditions, but also from social and economic aspects. 
It is known from the literature that species such as amphibians and fish possess a high 
capacity to regenerate damaged organs158-160. This remarkable capacity has been lost 
throughout evolution since mammals have a rather limited regenerative ability compared to 
lower species. This evolutionary loss is particularly evident in the adult mammalian heart that 
has been considered for a long time to be a post mitotic organ not able to self-renew161. 
Despite this evidence, recent studies show that murine neonatal hearts are able to regenerate 
after apical resection through cardiomyocyte proliferation162,163. Unfortunately, this 
remarkable ability of cardiomyocytes is lost within one week after birth, as more mature 
cardiomyocytes do not proliferate to regenerate the apical dissected heart. However, recent 
reports in human49,164 and mouse48 indicate that even the adult mammalian heart is able to 
regenerate upon damage. Moreover, it has been shown that the myocardial compartment, 
including cardiomyocytes, can also be renewed during aging to maintain the homeostasis of 
the heart49. These reports suggest that the heart, rather than a post mitotic organ, is a more 
dynamic system than previously thought. This concept opens up new perspectives in 
cardiovascular research that could be used for future therapeutic approaches. 
Even though the concept of heart as a dynamic organ has been generally accepted by the 
scientific community, the cellular source responsible for cardiac self-renewal is far from clear. 
Some studies suggest that heart regeneration depends on the presence of common resident 
precursor or stem cells (“cardiac progenitor/stem cells (CSCs)”)130-132, whereas other propose 
that existing cardiomyocytes contribute to this process by re-entering the cell cycle and 
dividing again 133,134. Both possibilities are currently investigated in the field of cardiovascular 
research. One hypothesis does not necessarily exclude the other and depending on the 
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condition (e.g. aging or pathological conditions), one source of renewal could be predominant 
over the other23. 
For instance, in 2007, using the MerCreMer-Z/EG mouse strain, Hsieh and collaborators 
could show that a pool of resident progenitor cells can differentiate into cardiomyocytes only 
in response to myocardial infarction, while under normal conditions these cells do not show 
any contribution48. This double transgenic mouse was obtained by mating the mouse strain 
line B6129-Tg(Myh6-Cre/Esr1)1Jmk/J (called αMHC-MerCreMer)48 with the Z/EG reporter 
strain. The αMHC-MerCreMer transgenic mouse is a tamoxifen inducible Cre-recombinase 
(Cre-ERT) strain, in which CreERT expression is under the cardiac-specific alpha myosin 
heavy chain promoter (Myh6). The Z/EG reporter mouse, instead, carries the lacZ gene fused 
with a stop codon flanked by two loxP sites, upstream of the GFP reporter (Figure 11). In the 
double transgenic mouse αMHC-MerCreMer-Z/EG, in the absence of tamoxifen, 
cardiomyocytes are positive for lacZ and do not express GFP. Upon tamoxifen injection, Cre-
ERT translocates into the nucleus and promotes the excision of the lacZ-stop codon cassette 
leading to the expression of GFP in cardiomyocytes. Using this mouse the group showed that 
during normal aging the number of GFP-labeled cardiomyocytes does not change. However, 
upon myocardial injury, the pool of the GFP-labeled cardiomyocytes is diminished. The 
authors speculated that this decrease is due to the existence of a pool of progenitor cells that 
are able to contribute to heart regeneration differentiating in cardiomyocytes which, in this 
case are negative for GFP. In contrast, under normal physiological conditions, the unchanged 
number of GFP-labeled cardiomyocytes leading the authors to conclude that cardiomyocyte 
turnover from the progenitor population does not take place. 
On the other hand, Bergmann et al.49 could show that cardiomyocyte renewal occurs even in 
adult human hearts during aging. The authors, by monitoring the incorporation of Carbon-14 
(14C) in the DNA of proliferating cells could prove that cardiomyocytes can be generated 
postnatally. They calculated that the percentage of cardiomyocyte turnover is approximately 
1% every year in individuals aged 25 year old, while this rate declines over time and is around 
0.45% in hearts from 75 year olds. In contrast to this low percentage, Kajstura et al.165, 
estimated that the human heart is completely replaced up to eight times during the human 
lifespan and this process seems to depend on C-kit+CSCs.  
The data described above support the hypothesis that CSCs are the cells contributing to 
cardiac regeneration. However, other studies demonstrated that, instead, adult cardiomyocytes 
re-enter the cell cycle and could be the real source for mammalian heart renewal. Two distinct 
research groups, focusing on the rate of cardiomyocyte DNA synthesis, found that myocyte 
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turnover under physiological conditions is present, although it was either really low 
(0.76%)134 or almost negligible (0.0006%)166. These differences in percentage could depend 
on the technique employed by the authors to score DNA synthesis. Nevertheless, this 
percentage increases up to 3.2%134 upon myocardial infarction. Independently from the 
conditions, the authors were able to show that this turnover is based on the division of pre-
existing cardiomyocytes. In order to do this, Senyo et al. took advantage of the MerCreMer-
Z/EG mouse strain described above48. Using [15N]thymidine, a base analogue that can be 
incorporated in the newly synthetized DNA during replication, they observed the presence of 
proliferating cardiomyocytes (15N+) positive for GFP. The presence of mononucleated 15N+-
GFP cardiomyocytes suggested that this fraction could only derive from the division of pre-
existing GFP+-cardiomyocytes134.  
Malliaras et al.167 reported that based on the conditions, both pre-existing cardiomyocytes and 
precursor cells do contribute to the regeneration of the heart. Under normal physiological 
conditions, the murine adult cardiomyocytes re-enter the cell cycle, divide and give rise to 
new cardiomyocytes at a rate of ~1.3-4% per year. However under pathological conditions, 
they found that the regenerated cardiomyocytes derive mainly from CSCs. Although the 
findings of Senyo et al.134 and Malliara et al.167 are intriguing, the results obtained in this 
thesis suggest a different scenario. The lineage tracing experiments performed in this study 
show that, in accordance with what has been observed in humans by Bergmann et al., in the 
murine heart, self-renewal also occurs under physiological conditions and the possible source 
of this renewal is represented by Sca1+CSCs. Sca1 is a specific marker for stem cells, 
including cardiac stem cells (CSCs)71,72,129, that is not expressed in mature cardiomyocytes. 
SCA1 immunostaining in isolated cardiomyocytes highlights that only a pool of small round 
cells attached to cardiomyocytes that express this marker (Figure 21). Using Sca1-tTA//LC1-
Cre//Z/AP mice, it was possible to observe that Sca1-expressing cells are able to contribute to 
the self-renewal of the major components of the myocardial compartment, including postnatal 
cardiomyocytes (Figure 17). In this mouse model, both the cells expressing Sca1 and Sca1-
derived cells are labeled with alkaline phosphatase (AP+, as described in section 6.1.1). Using 
this approach it was possible to identify, cardiomyocytes expressing alkaline phosphatase 
under physiological conditions, therefore demonstrating the existence of cardiomyocytes 
derived from Sca1-expressing cells. In particular, a fraction of AP+ mononucleated 
cardiomyocytes was constantly present regardless of the age (Figure 20). Cardiomyocytes are 
mature cells characterized by polyploidy (multiple sets of chromosomes), a phenomenon that 
usually occurs in cells in response to fusion events, aging or stress136. FISH (Fluorescence in 
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situ hybridization) experiments, performed in male Sca1-tTA//LC1-Cre//Z/AP mice, revealed 
that the pool of AP+ mononucleated cardiomyocytes presents only one Y-chromosome in the 
nucleus. This result confirms that these cells could not be derived from a fusion event of pre-
existing cardiomyocytes with Sca1-expressing AP+-cells. This evidence suggests the 
hypothesis that these cardiomyocytes could be derived from Sca1+-progenitor cells rather than 
from existing differentiated cardiomyocytes. Based on these data, the contribution of Sca1+-
cells to the physiological turnover of the heart was evaluated. It was shown, using mice of 
different ages (2 to 18 months old), that the absolute number of AP+-cardiomyocytes 
increases exponentially. This confirms a certain role of Sca1-derived cells in the maintenance 
of heart homeostasis during aging. However, as mentioned before, it has been published that 
CSCs contribute to heart regeneration only after damage, while no contribution under 
physiological conditions was observed48. Based on these results, the contribution of Sca1-
derived cells was analyzed using two different cardiac damage models: transverse aortic 
constriction (TAC) and myocardial infarction. Upon damage, the contribution of the Sca1-
expressing population was prominent as compared to the physiological conditions, confirming 
the study published by Hsieh and colleagues48. Moreover, it was observed that different types 
of damage influence the fate decisions of Sca1-derived cells towards one lineage rather than 
the other (Figure 18). TAC, for instance, is a model which leads to pressure overload-induced 
cardiac hypertrophy. The response to this damage consists of an enhancement of cardiac 
contractility that after a long period causes cardiac dilatation and heart failure. In this model, 
it was observed that Sca1-expressing cells differentiate more towards the cardiomyocyte 
lineage as compared to the other lineages. Independently from the time points studied (one or 
five months after the operation), the number of AP+-cardiomyocytes was approximately two 
times higher than in the control mice (Figure 18). Myocardial infarction, in contrast to TAC, 
does not affect the heart dimension. In this model, the damage is based on the permanent 
ligation of the left anterior descending artery (LAD) that leads to myocardial ischemia. The 
insufficient blood flow and therefore the low oxygen supply cause a loss of myocardial tissue 
resulting in scar formation. In this scenario no AP+-labeled cells, including cardiomyocytes, 
were detected either in the scar or in the border regions (Figure 18). However, a significant 
number of AP+-labeled endothelial cells were found in the septum area (Table 5). These 
observations support the idea that Sca1-expressing cells are resident stem cells able to 
differentiate into the cell types needed following cardiac remodeling, for example in response 
to myocardial infarction. In this regard, the external stimuli have a major influence in 
determining the differentiation fate of these precursor cells. In conditions where the oxygen 
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supply needs to be properly restored (e.g. myocardial infarction), the Sca1-expressing CSCs 
differentiate more into endothelial and smooth muscle cells rather than into cardiomyocytes, 
therefore increasing the number of vessels in the scar area. On the other hand, in the TAC 
model, Sca1-expressing CSCs give rise mainly to cardiomyocytes that might contribute to 
hypertrophy and higher cardiac contractility. Taken together, these data confirm the presence 
of a pool of progenitor cells, positive for Sca1, able to contribute to cardiomyocyte renewal 
under physiological and pathological conditions. However, the previous studies showed that 
under physiological conditions, heart renewal is achieved only by the proliferation of pre-
existing cardiomyocytes which re-enter the cell cycle and divide again, while no contribution 
of progenitor cells was reported167. The data examined so far in this thesis could support the 
idea that a population of CSCs expressing Sca1 is instead, involved in cardiomyocyte renewal 
during aging. This discrepancy could depend on the lineage tracing methods chosen and their 
relative limitations. For instance, since Sca1 is never expressed in adult mature 
cardiomyocytes, the role of pre-existing cardiomyocytes in heart renewal could not be 
analyzed in this thesis. On the other hand, in the previous investigations, the authors only 
focused on the contribution of cardiomyocytes not following the fate of precursor stem 
cells134. In both cases, the studies trace either pre-existing cardiomyocytes or CSCs, not taking 
into account the possible contribution of an alternative source for heart renewal. It is therefore 
important to evaluate at the same time, the contribution of CSCs and pre-existing 
cardiomyocytes during heart regeneration. In order to achieve this, one could cross the Sca1-
tTA//LC1-Cre//Z/AP mouse used in this thesis with the MerCreMer-ZEG mouse strain used 
by the other groups described above48,134,167. In the penta-transgenic mouse Sca1-tTA//LC1-
Cre//Z/AP//αMHC-MerCreMer-ZEG, the presence of cardiomyocytes labeled with alkaline 
phosphatase (i.e. derived from Sca1-expressing cells) but negative for GFP after tamoxifen 
induction would prove that these cells are derived from Sca1-expressing CSCs, rather than 
from the pre-existing cardiomyocytes. Furthermore, it would be possible to follow at the same 
time the turnover of GFP-labeled cardiomyocytes and the fate of Sca1-derived cells by 
comparing their contribution to heart regeneration. This approach would better elucidate the 
reason for the differences found between this thesis and the previous studies and might lead to 
a better understanding of the role of these two different sources in cardiac renewal. 
If CSCs do play a major role in regulation of the heart turnover and regeneration, so far these 
cells have not been well characterized. Besides SCA171,72,129, other different CSCs markers, 
such as ISL1168 and C-KIT130, have been identified. However, it is more likely that, rather 
than only one, a combination of different markers could define the CSCs population. Using 
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the Sca1-tTA//LC1-Cre//R26R-Confetti mouse strain it was possible to confirm that Sca1-
expressing cells represent a heterogeneous population consistent with previous work169 
(Figure 22). In Sca1-tTA//LC1-Cre//R26R-Confetti mice, Cre expression is under the control 
of the Sca1 promoter. In this mouse, Cre promotes the excision of the loxP sites present in the 
R26R-Confetti reporter mouse. The recombination removes the roadblock cassette resulting in 
individual Sca1-expressing cells labeled with the fluorescent protein presents right after the 
roadblock and randomly selected among the four proteins presented in the construct, such as: 
nGFP (nuclear green fluorescent protein); YFP (monomeric enhanced yellow fluorescent 
protein); RFP (red fluorescent protein); and mCFP (mCerulean cyan fluorescent protein) (as 
described in section 6.1.6). The fluorescent protein is retained by the daughter cells, therefore, 
the resulting clonal population will express the identical fluorescent tag. It was observed in 
this thesis that one color was not specific for a cell lineage, but each clone (color) was able to 
give rise to different cell lineages. For instance, yellow smooth muscle cells were detected as 
well as yellow cardiomyocytes. Furthermore, the analysis of different regions of the heart of 
Sca1-tTA//LC1-Cre//R26R-Confetti mice, revealed an unequal contribution of different Sca1-
expressing clones (characterized by different colors) within the same lineage. Moreover it has 
been observed that the ratio of cardiomyocytes and other cells types was not constant (Figure 
22e). These data could indicate that different Sca1-expressing clones may have differences in 
their potential to become mature cell types.  
Although lineage tracing using Sca1-tTA//LC1-Cre//R26R-Confetti mouse strain reveals 
certain heterogeneity of the Sca1-expressing CSCs, a further characterization of these cells is 
necessary. The identification of a pure population of CSCs will ensure an easier isolation of 
these cells for in vitro and in vivo studies as well as for their potential application in the 
clinical field. Currently, the most common method utilized to isolate cells is FACS 
(Fluorescence Activated Cell Sorting). FACS is a technique that allows separating distinct cell 
populations according to their cell surface markers. In order to specifically characterize CSCs, 
these cells were first isolated from the total fraction of the adult murine heart and their 
transcriptomic profile was analyzed using microarrays. The output was compared to 
microarray data of other cell types (e.g. murine embryonic stem cells, endothelial cells). The 
obtained CSCs transcriptome was more similar to cardiac fibroblasts than to that of other cells 
types (Figure 23). The microarray data of cardiac fibroblasts were obtained from fibroblasts 
successful reprogrammed into cardiac stem cells170-171. The similarity found between the 
CSCs and cardiac fibroblasts confirmed the potential plasticity of these cells, the same 
normally acquired by reprogrammed cells. However, these data are related to a fraction of 
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CSCs not completely pure for Sca1. The CSCs were isolated using a Millipore kit that 
guarantees purity up to 50% in the SCA1-expressing cells. In respect to identifying a unique 
expression profile for pure Sca1-expressing CSCs, these cells were individually sorted using 
SCA1 as a surface marker, while populations expressing CD31 (marker for endothelial cells) 
and CD45 (marker for hematopoietic cells) were excluded. Immunostaining against 
transcription factors considered typical for stem cells (Figure 23d) revealed that not all 
Sca1+CSCs cells possess the same expression level of typical stem cell markers such as 
ABCG2, SOX2 and NANOG. The majority of them are positive for ABCG2 and SOX2 
(32%), whereas only a small number of cells express NANOG (0.88%). These data further 
confirm the heterogeneity of Sca1+CSCs cells. It is known that although cells isolated by 
FACS present the same specific cell surface marker, this does not guarantee the homogeneity 
of the population. Indeed, cells belonging to the same population at the single cell level might 
not have a unique molecular signature because the gene expression may not reflect the level 
of the corresponding protein172-175. This is due to the fact that transcription and translation are 
stochastic events, leading to a content of mRNA and proteins that differs from cell to cell176. 
To uncover such cell to cell variability, new techniques have been developed in recent 
years176,177. One of them is a method developed by Fluidigm Corporation178 consisted of high-
throughput real-time single cells PCR. This method take advantage of specific chip cards that 
are composed of different microfluidic chambers and channels in which individuals PCR 
reactions occur at the same time. In particular, using this method the selected primers are 
loaded in one side of the chip, whereas the samples are located in the other one. The solutions 
are, then, primed together and pressurized inside the micro-channels, where the real time PCR 
reaction is performed using a real time PCR machine (BioMarkTMHD Reader). In order to set 
up multiple reactions, the strategy of this technique is that all the reactions are run using the 
same melting temperature (60°C) and as a consequence, all the primers considered have to be 
designed following this specific criterion. In this dissertation this technique was utilized to try 
to define a specific and homogenous profile for Sca1-expressing CSCs at single cell gene 
level. 
Although the heterogeneity of the sorted SCA1+CD31-CD45- CSCs remained high, the 
analyses of single-cell transcriptomic data generated through BioMarkTMHD System revealed 
a clear and defined common signature of Sca1+CSCs. Among all the different genes 
considered in the analyses and known to be related to the heart and stem cell field, three of 
them were highly expressed in all the single Sca1+CSCs studied: Nestin, Tgfb3 and Stat2. 
Nestin and Tgfb3 have already been described in literature to be involved in heart 
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regeneration. Nestin has been identified as a marker for CSCs by a number of researchers in 
the past179,180, while a point mutations of Tgfb3 have been causally linked to arrhythmogenic 
right ventricular cardiomyopathy (ARVC) disease, possibly due to defects in cardiac 
progenitor cells181. Stat2 has been shown to have a role in regulating myogenic differentiation 
in satellite cell derived myoblasts182 but so far, it has never been reported to be associated 
with cardiomyocytes and cardiomyocyte progenitor cells. These data lead to the conclusion 
that based on the presence of Stat2, Nestin and Tgfb3 genes, within Sca1+CSCs it is possible 
to identify a subpopulation of cell presenting a common gene expression profile. 
The heterogeneity observed in vivo using R26R-Confetti mice and in the single cell 
transcriptional profiling of CSCs could give a possible explanation for the differences in terms 
of number and contribution of these cells in the heart turnover observed by distinct research 
groups. Based on the labeled population, it could be that only a small fraction of CSCs were 
analyzed, while a complete overview of the regenerative capability of CSCs is still missing. In 
this perspective, the data shown in this thesis have their own limitations. On one side, in the 
lineage tracing approach used in the present work, only CSCs cell expressing Sca1 were 
analyzed and characterized, while the contribution of other CSCs cells that might not express 
Sca1 was not considered. On the other hand, although Sca1+CSCs could represent a very 
interesting source of cardiac stem cells to be further investigated in order to be used in the 
clinic, Sca1 does not seem to be a good marker for isolation of CSCs from human patients. 
Although some groups were able to isolate cardiac progenitor cells from human fetal and 
adult hearts using anti-murine SCA1 antibody183, the human ortholog of Sca1 has not been 
identified so far76. To overcome this problem, instead of using Sca1 as a marker to isolate 
human CSCs, one possibility could be to consider other markers that in this study have shown 
high significance at single cell transcriptomic level. Nevertheless, even with of these 
restrictions it was possible to define a unique population of CSCs in this thesis. Another 
important goal would be to find a way to manipulate these cells in order to stimulate their 
differentiation toward particular cell types (e.g. in the heart into cardiomyocytes), that would 
make these cells particularly attractive also for clinical purposes. In particular, it will be 
interesting to understand the molecular pathway that regulates the differentiation process of 
Sca1+CSCs toward the different mature cell types. In this regard the experiments performed in 
this study could be helpful to find certain substances that could be used as possible drugs to 
stimulate the differentiation Sca1+CSC. Following this idea, the mouse model used in this 
thesis could be considered a good tool to screen in vivo which substances are more effective. 
The Sca1-tTA//LC1-Cre//Z/AP mouse is under the control of the Tet-off system meaning that 
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in the presence of doxycycline tTA is not able to bind the operator and the transcription of 
Cre-recombinase is repressed. In the absence of Cre the cells expressing Sca1 will be positive 
for lacZ whereas alkaline phosphatase labeling will not occur. One possible idea could be to 
administer doxycycline and suppress the AP-labeling of the cells until the administration of 
inhibitors for instance. After the drugs injection, the administration of doxycycline will be 
removed and the cells expressing Sca1 will start to express alkaline phosphatase. In this 
context, if the substance chosen could stimulate Sca1+CSCs differentiation, it could be 
possible to find an increased number of AP+-cardiomyocytes compared to the untreated 
control. Another possible read out of the efficiency of the substances chosen could be to test 
them in vitro. During this study, several attempts were made to culture the isolated Sca1-
expressing CSCs but unfortunately these cells quickly became senescent and no further 
experiments were possible. However, it was observed that in vitro, Sca1-expressing cells are 
normally attached to the cardiomyocytes and specifically located under the basal lamina of 
cardiomyocytes, which in this dissertation has been proposed to be the possible niche for 
CSCs (Figure 21). Taken these results into account, a possible way to cultivate these cells 
would be to isolate cardiomyocytes together with the attached CSCs and co-culture them. For 
this purpose, it might be useful to utilize the Sca1-GFP mouse line already considered in this 
thesis to identify the niche of Sca1-expressing cells. In this mouse, the expression of GFP is 
controlled by Sca1 gene regulatory sequence. In particular, Sca1-expressing cells are labeled 
by GFP, since GFP is under the endogenous promoter of Sca1, however after their 
commitment towards mature cells types (e.g. cardiomyocyte) the GFP signal is lost due to the 
fact that the differentiated cells do not express Sca1 any longer, as previously mentioned. It 
has been observed in this thesis that in normal culture conditions Sca1-positive cells 
preferably remains quiescent and do not spontaneously differentiate. As a consequence, if the 
substances chosen could specifically stimulate only Sca1-expressing cells to differentiate 
towards cardiomyocytes lineages in vitro for instance, the GFP signal in these cells should be 
lost and performing a counterstain with cardiac marker specific (e.g. alpha myosin heavy 
chain, dystrophin, phalloidin) should reveal an increase number of mononucleated 
cardiomyocytes.  
In conclusion, this study demonstrates the existence of resident cardiac progenitor cells 
expressing Sca1 in the murine adult heart. They seem to be located in a specific position, 
attached to cardiomyocytes and under the basal lamina, similarly to satellite cells in the 
skeletal muscle. It is proposed here that these Sca1+-cells can give rise to different mature cell 
types upon differentiation. These mature cell types include cardiomyocytes, which can be 
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replenished during the normal aging process to maintain the homeostasis of the heart, albeit in 
a limited manner. Furthermore, these cells are directed to a certain lineage upon external 
stimuli caused by myocardial damages (Figure 35). Further work based on this study is 
essential to further characterize these cells and identify the molecular mechanisms that control 
their behavior in response to specific drug treatment, in order to understand if Sca1+-cells 








7.2 Evidence that Sca1-expressing cells are a source of skeletal 
muscle renewal and regeneration  
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In the skeletal muscle, the contribution of resident stem cells to regeneration of muscle fibers 
has been studied in more detail as compared to the heart.  
The classical “dogma” in skeletal muscle research is that only one stem cell type is present, 
the so called “satellite cells”59,184. Since their discovery in 196141, satellite cells have been 
described to be a unique population of stem cells in the muscle that are able to self-renew and 
are characterized by the expression of protein markers such as C-MET, CD34, M-
CADHERIN and the transcriptional factor PAX7. Satellite cells reside underneath the basal 
lamina and are able to differentiate in mature myofibers maintaining the muscle homeostasis 
and thereby contribute to skeletal muscle repair. In contrast to the classical definition of stem 
cells185-188 which are able to differentiate in multiple lineages (multipotency), satellite cells 
show only myogenic commitment in vivo189. Although satellite cells are the muscle stem cell 
par excellence, in the recent years other stem cell populations have been identified in the 
skeletal muscle. These include: Fibro-Adipo Progenitors cells (FAPs)63,64,152, Progenitor 
Interstitial Cells (PICs)60,190, pericytes191, mesangioblasts192 and Muscle Derived Stem Cells 
(MDSCs)66. Some of them clearly regulate satellite cells quiescence and differentiation to 
balance the myogenic regeneration (FAPs, PICs), while others show multipotency for 
example MDSCs (Figure 36). MDSCs are indeed able to self-renew and to differentiate, both 
in vitro and in vivo, into distinct lineages and therefore are, among all muscle stem cells the 
ones showing more features of classical stem cells. It has been shown in addition that 
transplantation of MDSCs leads to a better regeneration and higher dystrophin delivery in the 
dystrophic mouse model193, as compared to satellite cells. Interestingly, a common 
characteristic among all the muscle stem cells populations described above, beside satellite 
cells, is the expression of stem cell antigen 1 marker (Sca1).  
Using the same mouse model as in the heart lineage tracing studies (Sca1-tTA//LC1-
Cre//Z/AP) it was also possible to monitor the fate of Sca1 progenitor cells in vivo in the 
skeletal muscle. In Sca1-tTA//LC1-Cre//Z/AP mouse, once a cell expresses Sca1, Cre is 
transcribed and the cell is permanently labelled with alkaline phosphatase. Since alkaline 
phosphatase has been described in the literature by Cappellari et al. to be a marker for 
pericytes194, another stem cell population identified in the skeletal muscle, one could argue 
that the lineage tracing performed in this thesis simply traced their fate. However, since the 
Z/AP allele produces human Placental Alkaline Phosphatase (hPLAP), using a specific 
antibody for hPLAP (AP) and the described mouse model, it was possible to rule out the 
simple tracing of pericytes and discriminate them from the cells expressing hPLAP. The in 
vivo data shown in section 6.2.1 demonstrate that a Sca1-expressing cell population is able to 
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partially contribute to muscle regeneration under normal physiological conditions. In fact in 3 
to 18 month old mice it was possible to detect AP+-fibers, although their number decreased 
from younger to older mice confirming how aging affects the ability of Sca1-derived cells to 
give rise to myofibers. Since the number of AP+-fibers detected in cross-sections of the 
skeletal muscle in these conditions was extremely low, muscle damage was induced in Sca1-
tTA//LC1-Cre//Z/AP mice to examine if the subsequent muscle regeneration could stimulate 
Sca1-expressing cells to differentiate more into the myogenic lineage. As a first approach, the 
regeneration was monitored, in response to muscle damage induced by a single cardiotoxin 
injection (snake venom able to destroy myofibers), according to the literature195. Although, 
after damage, a slight increase in the number of AP+-fibers was detected, this was not 
significant compared to the physiological condition (Figure 24 a & b). This result might be 
due to the fact that one cardiotoxin injection represents soft damage, not sufficient to properly 
activate Sca1-expressing cells. Therefore severe damage conditions were used by performing 
one cardiotoxin injection every month for a total period of three months (Figure 24). Although 
the contribution to muscle regeneration of Sca1-expressing cells remained less than satellite 
cells, a slight increase in the number of labeled myofibers after three injections was observed 
as compared to mice injected only once. This behavior seems to be similar to the 
hematopoietic “dormant” stem cells196, described in the literature as a quiescent cell 
population not able to participate in normal hematopoiesis. However, upon severe damage 
(e.g. bone marrow injury), these dormant stem cells proliferate and differentiate in all blood 
cell types. These data confirmed that, although satellite cells still represent the major source 
of muscle regeneration, Sca1-expressing cells might function as a reservoir of stem cells upon 
severe damage. One hypothesis might be that the regeneration process sustained by satellite 
cells upon repetitive injury seems to be insufficient and as such other types of stem cells, 
normally dormant (i.e. Sca1-expressing cells), start to differentiate and assist satellite cells in 
myofiber formation. Furthermore, it was speculated that Sca1-expressing cells show higher 
myogenic contribution in an environment where a continuous regeneration occurs thereby 
promoting continuous stem cell differentiation. An example of such an environment could be 
represented by degenerative disorders leading to skeletal muscle wasting, such as muscular 
dystrophies197. Duchenne dystrophy is one of the most common muscular dystrophies which 
affects 1 in 3500 male birth in the world. It is a recessive X-linked disease characterized by a 
total absence or a defect (usually a point mutation) in the dystrophin gene. Dystrophin is a 
cytoskeletal protein present in the myofiber sarcolemma, involved on the linkage between the 
cytoskeleton and the extracellular matrix198. A defect in the dystrophin protein leads to muscle 
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membrane abnormalities which influence myofiber functionality. Although satellite cells in 
this disease are perfectly functional, the constant muscle damage, continuously stimulates 
satellite cells to enter the cell cycle and differentiate into new fibers leading to 
impoverishment of the stem cell reservoir199. Gene therapy, exon skipping and cell therapies 
are the common approaches under investigation to treat this pathology, even if the clinical 
results still remain disappointing200. In the research field, the mdx (X-linked muscular 
dystrophy) mouse represents the experimental Duchenne dystrophy model. The mdx mouse is 
a modified genetic strain in which the exon 23 of the dystrophin gene carries a non-sense 
point mutation that causes abnormal dystrophin production and consequent progressive 
degeneration of the skeletal muscle201. However, in mdx mice spontaneous somatic reversion 
of the mutation occurs, generating a limited number of dystrophin positive fibers called 
“revertant” fibers202, able to promote partial muscle regeneration. Furthermore it has been 
described that presence of longer telomere as well as normal telomerase activity in mice203 are 
the reason of lifespan prolongation in the mdx mice as compared to humans. A patient 
affected by Duchenne dystrophy, in fact, can survive a maximum of 35 years; while mdx mice 
normally die when they are around 15-19 months old. Although mdx mice show some features 
different from the human Duchenne dystrophy, they can be considered as a good animal 
model for both genetic and biological studies204. Different studies have shown that although 
ex vivo transplantation of satellite cells obtained from healthy donor mice into mdx host mice 
increases the level of functional dystrophin positive fibers, in general their contribution turned 
out to be poorly efficient and did not lead to any significant benefits205,206. A possible 
explanation of the low efficiency of satellite cells in a degenerative environment might be 
that, in this situation, satellite cells are not able alone to rescue skeletal muscle regeneration 
but they rather need the support of other stem cells. In this study, the contribution of Sca1-
expressing cells in myofiber formation was investigated in mdx mice as model mimicking a 
condition of extreme muscle damage. Sca1-tTA//LC1-Cre//Z/AP mice were crossed with mdx 
mice and injected each month with cardiotoxin for a total of three times. In this context, it was 
found that in young mice the number of Sca1-derived myofibers increased as compared to the 
not injected contralateral muscle (TAR), therefore used as a control (3 months old: 
0.11±0.0034% in TAR and 0.18±0.0037% in TAL). Contrarily, in the older mice (6 months 
old) this number was decreased slightly, even though newly regenerated fibers (center-
nucleated) were detectable (Figure 25d). This approach demonstrates that Sca1-expressing 
cells have a higher contribution in muscle fiber regeneration under pathological conditions. 
These data could support the hypothesis that Sca1-expressing cells are dormant stem cells 
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able to be properly activated only in extreme adverse environments. As mentioned above, the 
repetitive cycles of regeneration occurring in mdx mice lead to a constant activation and 
differentiation of the satellite cells impoverishing their pool. In this respect, Sca1-expressing 
stem cells could represent a possible source of stem cells able to be recruited to replenish the 
stem cell pool184 and contribute to muscle regeneration. 
The involvement of Sca1-expressing cells in muscle regeneration under both physiological 
and pathological conditions, do not however clarify the question whether these cells are a 
population of stem cells distinct from satellite cells or not. In 2013, a population of muscle 
stem cells which express SCA1 and the satellite marker PAX7207 was identified. In this regard 
the in vivo results showed in this study may be a mere observation of a subset satellite cells 
expressing SCA1. However, the presence of alkaline phosphatase labeled myofibers in the 
Sca1-tTA//LC1-Cre//Z/AP//Pax7loxPGu/loxPGu mouse model rebuts this point. In this mouse 
model, when a cell expresses Sca1, Cre is transcribed and recombines the loxP present in both 
Z/AP and Pax7loxPGu/loxPGu strains. The recombination leads to the permanent labelling of 
Sca1-expressing cells with alkaline phosphatase and to the excision of the exons 1-3 from 
Pax7 gene resulting in a loss of expression of Pax7 (Figure 26a). Pax7 is a transcription factor 
which belongs to the family of paired-box proteins. It is involved in different developmental 
processes and is one of the most common markers specific for quiescent satellite cells. When 
the satellite cells start to differentiate, the expression of this marker is shut down208. Although 
the function of Pax7 has been shown to be required for the myogenic determination of 
satellite cells during embryonic stages, it is still not clear if it is also necessary on 
adulthood144. Accordingly Seale et al.209 demonstrated that, although in Pax7 deficient mice 
(Pax7-/-) satellite cells are completely absent, another distinct type of muscle stem cells exists 
that does not express Pax7. In the absence of PAX7 expression, this population showed high 
in vitro hematopoietic potential, whereas when they express the PAX7 their potency is limited 
to satellite cells commitment. In contrast with these results, Sambasivan et al.210 demonstrated 
that the role of PAX7+ satellite cells is also fundamental for the regeneration of muscle fibers 
in adult stages. More recently, Günther et al.111, developed the mouse model Pax7loxPGu/loxPGu 
(used also in this thesis) and confirmed the importance of Pax7 in the myogenic commitment 
of stem cells during adult stages. In particular, the authors showed that the deletion of Pax7 
gene in adult Pax7+ and Myf5+ cells population leads to respectively completely satellite cell 
loss and in impaired muscle regeneration. The debate concerning the role of satellite cells in 
adult stage and the presence of other source of stem cells remains open. The results obtained 
in this thesis using Sca1-tTA//LC1-Cre//Z/AP//Pax7loxPGu/loxPGu mouse model, suggest the idea 
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of the presence of a population of stem cells distinct from satellite cells. Normally a muscle 
stem cell requires to sequentially express Pax7, Myf5, MyoD and Myogenin to become a 
fiber211, however the presence of AP+-labeled myofibers in Sca1-tTA//LC1-
Cre//Z/AP//Pax7loxPGu/loxPGu mouse (Figure 26) confirmed the existence of Sca1-expressing 
cells that are able to differentiate towards the myogenic lineage without the requirement of 
Pax7 expression. This contribution to muscle regeneration was rather limited both under 
normal physiological and after cardiotoxin damage. Based on the data showed by Lepper et 
al. 144, supporting the idea that during the muscle regeneration Pax7 expression is not required 
after postnatal day 21 (P21), Sca1-expressing cell contribution was also investigated before 
P21. An increased number of labeled fibers was present in Sca1-tTA//LC1-
Cre//Z/AP//Pax7loxPGu/loxPGu mice at P21 (Figure 27) injected with cardiotoxin at P14, as 
compared to the uninjected control mice. These observations lead to the conclusion that a 
subpopulation of Sca1-expressing cells is able to differentiate into myofibers independent of 
Pax7 expression in neonatal stages. The increased number of AP+-myofibers detected in the 
neonatal mice as compared to the adult stage suggest that, in a young environment, Sca1-
expressing cells are more active. However, one should take into account that Günther et al. 
111, using the inducible Cre Pax7CE/loxPGu transgenic mice, showed that upon tamoxifen (TAM) 
injection the subsequent deletion of Pax7 does not immediately lead to the loss of all satellite 
cells. Instead there is an almost complete deletion only after 30 days post TAM injection. 
Based on these data, the presence of more AP+-fibers during neonatal stages in Sca1-
tTA//LC1-Cre//Z/AP//Pax7loxPGu/loxPGu model, could depend on the presence of a 
subpopulation of satellite cells expressing Sca1. However as described by Gunther et al.111 
after 14 days after birth, time point chosen in this thesis to induce muscle damage, the satellite 
cells presence is almost negligible ensuring that the Sca1-expressing cells contributing to 
muscle regeneration are the one that already lost satellite cell characteristics. These data 
propose that, in a small population of Sca1-expressing muscle resident stem cells, the function 
of Pax7 seems not to be crucial, although it remains indisputable that satellite cells are the 
myogenic precursor population with the higher contribution in muscle regeneration.  
As previously reported189, satellite cells lack the ability to differentiate into cell types other 
than myofibers in vivo, whereas cells expressing Sca1 and positive also either for 
PDGFRalpha-positive63 or alpha7INTEGRIN64, namely FAPS63,64, are multipotent. FAPs 
have been reported to be a cell population completely distinct from satellite cells, that is able 
to differentiate into fibrotic and adipose tissues. They seem to play a major role in balancing 
the muscle regeneration and fibro-adipose tissue content under physiological conditions and 
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in response to damage through the release of chemokine (e.g. IL6). Interestingly, it has been 
recently shown that the expression of SCA1 and PDGFRalpha in PICs, another muscle stem 
cells population, could define a subpopulation also able to give rise to fibroblast and 
adipocytes. PICs have been defined by Mitchell et al.60 to be positive for nuclear protein PW1 
(PEG3) and able to give rise to myofibers only in the presence of satellite cells. Furthermore, 
within PICs, Pannérec et al.190 have identified three subpopulations defined as follows: (1) 
SCA1- PICs, positive either for NG2/AP or for Pax7 that are able to differentiate into 
myofibers; (2) SCA1+ PICs, that do not need the expression of Pax7 to differentiate into 
myofibers; (3) SCA1+/PDGFRalpha+ PICs, that are able to give rise to adipocytes.  
In this thesis, the capability of Sca1-derived cells to differentiate into other mesodermal 
lineages beside the myogenic one was confirmed by injections of BMP4 and BMP7 into the 
tibialis anterior muscle of Sca1-tTA//LC1-Cre//Z/AP and Pax7-Cre/Z/AP mice . These BMPs 
molecules are known to promote the formation of bone149 and fat150 respectively. The 
administration of BMP4 and BMP7 in combination or alone in Sca1-tTA//LC1-Cre//Z/AP 
suggested a contribution of Sca1-expressing cells in the formation ectopic bone and fat, 
confirming the potential of Sca1-derived cells committed into different cell lineages (Figure 
25). Satellite cells, contrarily, do not participate to this process. In this work the fate of 
satellite cells and their contribution to fat and bone formation was traced using the transgenic 
mouse model Pax7-Cre/Z/AP. In this mouse the Cre expression is under the control of Pax7 
promoter therefore in the cells expressing Pax7 (satellite cells) the Cre expression recombine 
the loxP in the Z/AP reporter locus, leading to permanent labeling these cells with alkaline 
phosphatase. In this mouse in response to BMP molecule treatment, performed as mentioned 
above, it was shown that satellite cells do not contribute to the ectopic tissue formation 
(Figure 28). These data clarified that satellite cells in vivo are unable to give rise to either 
osteoblasts or adipocytes, opposite of what has been shown previously by Asakura et al.149 
using isolated satellite cells. In this work the authors could show that in vitro satellite cells, 
after treatment with BMP4 and BMP7, are able to differentiate into other lineages different 
from the myogenic one, indicating that probably some other cell populations could inhibit in 
vivo the differentiation of satellite cells. In this dissertation, it was shown that a population of 
stem cells expressing Sca1 exists, which is able to contribute to ectopic tissue formation in 
vivo. In particular, Sca1-expressing cells differentiate in vivo into the three mesordermal 
lineages (myogenic, adipogenic and osteogenic lineages) whereas the differentiation potential 
of satellite cells in vivo is only myogenic. The possible explanation of the differences in the 
plasticity of these two populations could be due to differences in the gene profile of these 
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cells. Transcriptomic analyses of three different muscle populations (i.e. satellite cells, FAPs 
and Sca1-expressing cells) in both quiescence and activated state, highlighted the possible 
reason for the different behavior of the satellite cells and Sca1-expressing cells observed in 
vivo. Satellite cells, both in quiescence and activated state, showed mainly an up regulation of 
the genes involved in myogenesis (e.g. Pax7, Myf5, MyoD), whereas Sca1-expressing cells, 
after activation, presented an up regulation also of genes specific for fibrogenesis (e.g. Fsp1, 
Itga, Smad1, P4hb), adipogenesis (e.g. Bmp7,C/ebp gamma, Cidea, PPRgamma) and 
osteogenesis (Bmp4) (Table 6). Regarding the adipogenic pathway an interesting gene was 
identified and namely Prdm16. PRDM16 has been shown to be involved in the 
transdifferentiation of C2C12 into brown adipocytes through PPRgamma binding 
regulation212. The microarray analyses showed that Sca1-expressing cells present a low 
expression of Prdm16, whereas PPRgamma is up regulated (Figure 31c). This high 
expression could probably be sufficient to stimulate the adipogenic commitment of these stem 
cells. On the other hand, in satellite cells, both Prdm16 and PPRgamma genes show a low 
expression level. These results could possibly explain why, although the high expression of 
other adipogenic genes (e.g Adiponectin, Elovl3, Adipsin, Cidea), satellite cells are not able to 
form adipose tissue in vivo. The administration of BMP molecules performed in this study 
showed an involvement of Sca1-expressing cells not only in the adipogenesis but also in 
osteogenesis. To dissect this observation more carefully, the expression of genes related to the 
osteogenic pathway was examined. Acvr1213 and Bmp4214 are upregulated in quiescent Sca1-
expressing cells, but their expression level decreased after activation. These data support the 
hypothesis that Sca1-expressing cells have the potential to be committed towards osteogenic 
lineage although cardiotoxin injection does not activate this pathway (Figure 31d). 
Furthermore, in the gene array dataset, two genes clearly marked a division between satellite 
cells and Sca1-expressing-FAPs cells (Figure 31d), such as Bmp1 and Il6. Bmp1 is known to 
be involved in the activation of latent myostatin, a negative regulator of muscle growth215 and 
it has also been shown to be involved in cartilage formation216. Bmp1 is expressed in Sca1-
expressing cells and FAPs, whereas in satellite cells its expression is quite low, both in 
quiescence and activated state. Satellite cells are important in muscle formation and repair and 
it has already been shown that myostatin inhibits satellite cell renewal and activation217. The 
low expression level of Bmp1 in satellite cells population could determine the inactivation of 
myostatin explaining the higher ability of satellite cells to participate to muscle formation and 
repair. Contrarily, the high expression level of Bmp1 in quiescent Sca1-expressing cells and 
FAPs suggests that the differentiation ability of Sca1-expressing cells towards myofibers 
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could be inhibited by the expression of this gene. This is in accordance with the fact that 
Bmp1 has a really low expression after activation, when the Sca1-expressing cells probably 
activate their myogenic pattern. As mentioned above Bmp1 is also involved in cartilage and 
bone formation. Thus, another possible explanation of the high level of Bmp1 in Sca1-
expressing cells might be that these cells are able to differentiate also into cartilage. On the 
other hand Il6 is known to be involved in satellite cells-mediated muscle hypertrophy and 
induction of muscle growth155. Furthermore, the importance of Il6 as a released factor that is 
able to regulate the quiescence and activated state of satellite cells has already been shown by 
other groups64. Taken together this evidence, it might allow one to hypothesize that the high 
expression level of Il6 in Sca1-expressing cells after activation could be a key regulator in the 
promotion of the myogenic commitment of these cells. 
The different expression levels of Bmp1 and Il6 seem to be a possible regulator of the 
different myogenic potential observed in satellite cells and Sca1-expressing cells. 
Interestingly, a specific profile of these two genes also emerged at the single cell level in 
satellite cells and FAPs either in presence or absence of Sca1 expression. FAPs are described 
in the literature to be positive also for Sca1 so the presence of a subpopulation expressing this 
marker within the population sorted for PDGFRalpha is not surprisingly. Regarding satellite 
cells, although they have been described as a heterogeneous population, composed of 
different subpopulations containing cells that differ from each other to a certain level156, the 
existence of a subpopulation of satellite cells positive for Sca1 has not been so far clearly 
defined. For instance, in 2009, Olwin and colleagues218 identified a population distinct from 
satellite cells but with myogenic characteristics similar to them. They describe this population 
to be positive for Syndecan4, Syndecan3, Pax7, the SP marker ABCG2 and Sca1. The authors 
proved that this population has high quiescent capability and enhanced stem cell 
characteristics. These characteristics might be derived from the presence of Sca1. The single 
cell analyses performed in this thesis show that satellite cells in the presence of Sca1 express 
low level of IL6-st (IL6 receptor subunit beta) and high expression level of Bmp1. Based on 
the fact that Il6 has been described to promote muscle differentiation155, whereas Bmp1 
inhibits this process215, these results might explain the role of the two genes in the 
maintenance of the quiescent state in the subpopulation of satellite cells expressing Sca1 
(Figure 34). To test such hypothesis, one possible experiment would be to isolate SCA1+ and 
SCA1- satellite cells by FACS. Both cell types are then treated with a BMP1 inhibitor to score 
for their differentiation capability in vitro upon myogenesis induction. Furthermore, based on 
the arrays data, either Western blot or ELISA (Enzyme-linked immunosorbent assay) could be 
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performed to determine whether IL6-st is also present at the protein level in these populations. 
Once the presence of the receptor in vitro is established, it will be possible to monitor the 
behavior of the two sorted cell populations cultured with different concentrations of IL6.  
In conclusion, this study provides evidence that Sca1-expressing cells could be considered as 
muscle stem cells. Using lineage tracing approaches, it has been shown that Sca1-expressing 
cells are multipotent and are able to differentiate into other mesodermal lineages (i.e. adipose 
and osteogenic tissue), although their contribution to myofibers is rather limited compared 
satellite cells. The transcriptomic profile of Sca1-expressing cells highlighted the difference 
between this population and satellite cells, entertaining the idea of a possible distinct muscle 
stem cell population that expresses Sca1 and is highly quiescent (Figure 37). A source of stem 
cells more plastic and multipotent (i.e. Sca1-expressing cells) could be an advantage in 
clinical treatment of skeletal muscle disease since satellite cells alone have not been shown to 
be sufficient after stem cell transplantation. It will be therefore important to refine the Sca1-
expressing cells isolation and elucidate possible methods to expand this population. A 
possible combination of transplanted satellite cells and Sca1-expressing cells could be, 
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Figure 36. Classical overview of stem cell contribution in the skeletal muscle. 
 
 
Figure 37. New possible scheme illustrating the muscle stem cells contribution in skeletal muscle.  
The cartoon summarizes and links all the possible sources of stem cells in the skeletal muscle and their possible 
contribution during the regeneration event. 
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8 ABBREVIATIONS 
µl     microliter 
µM     microMolar 
14C     Carbon 14 
4-OHT    4-hydroxy-tamoxifen 
Abcg2    ATP-binding cassette sub-family G member 2 
aCFibro   murine adult cardiomyocytes 
Actbeta   beta actin 
Acvr1     Activin receptor type 1 
AFP    alpha fetoprotein 
aHeart    murine adult heart 
Airn    Antisense of IGF2R Non-Protein Coding RNA 
aKEndo   glomerular endothelial cells from adult Tie2-GFP mice 
alphaMHC   alpha Myosin Heavy Chain 
alphaSMactin   alpha smooth muscle actin 
AP    Alkaline phosphatase 
aP2    adipocyte protein 2 
BCIP    5-Bromo-4-chloro-8-indolilphosphate  
BD    Becton Dickinson 
BEX1    Brain-expressed X-linked protein 1 
BMCs    Bone Marrow Cells 
BM-MASCs   Adult bone marrow-derived multipotent mesenchymal stem cells 
BMP(1,4,7,9)   Bone Morphogenic Protein 
BS-1    bandeira simplicifolia 1 
C/EBPalpha/beta/gamma enhancer-binding protein alpha/beta/gamma 
C    Cytosine 
CaCl2    Calcium chloride 
cc    cubic centimeter 
CD(31,34, 45,79a etc)   Claster of Differentiation 
cDNA    complementary Deoxyribonucleic acid 
CFP    cyan fluorescence protein 
Cidea    cell death activator 
C-KIT proto-oncogene c-Kit or tyrosine-protein kinase Kit or CD117 or 
Mast/stem cell growth factor receptor (SCFR) 
 
CLARA   a sampling-based algorithm, implementation of PAM 
CMV    cytomegalovirus 
CPs    Cardiac progenitor cells 
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Crabp2a   cellular retinoic acid-binding protein 2 
Cre    Causes or Cyclization recombinase 
CSCs    Cardiac Stem Cells 
Ct    threshold cycle 
CX43/45   Connexin 43/45 
Cxcl9    Chemokine (C-X-C motif) ligand 9 
CY2/3    Cyanine 2/3 
DAPI    4',6-Diamidino-2-Phenylindole, Dihydrochloride 
ddCt    delta delta threshold cycle 
ddH2O    double-distilled water 
DDR2    Discoidin Domain Receptor 2 
DIANA   DNA Intelligent Analysis, divisive hierarchical approach to clustering  
Dil    1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine  
Dio    3,3´ -dioctadecyloxacarbocyanine  
DMEM   Dulbecco´s modified eagle medium 
DNA    Deoxyribonucleic acid 
EAA    Exon Array Analyzer 
EGFP    enhanced fluorescence protein 
Elovl3    elongation of very long chain fatty acids 
Eltd1    EGF, latrophilin seven transmembrane domain containing 1  
Emsd    eomesodermin 
Endo.N. endothelial cell lines derived from murine embryonic stem cells 
expressing N-cadherin 
 
Endo.VE. endothelial cell lines derived from murine embryonic stem cells 
expressing VE-cadherin 
 
Endo.VE+N endothelial cell lines derived from murine embryonic stem cells 
expressing both N-cadherin and VE-cadherin 
 
ER    Estrogen Receptor 
ERT    estrogen receptor responsive element 
ESs    Embryonic Stem cells 
FACS    Fluorescence-Activated Cells Sorting 
FANNY   algorithm performs fuzzy clustering 
Fap    Fibroblast Activation Protein 
FAPs    Fibro-adipogenic precursor cells 
FCS    Fetal Calf Serum 
FGFR-4   Fibroblast growth factor receptor 
FISH    Fluorescence in situ hybridization 
FITC    fluorescein isothiocyanate 
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Flk-1 Fetal Liver Kinase 1, a receptor for vascular endothelial growth factor 
(VEGF) 
 
FoxC2/D3   Forkhead box protein 
FSP1    Intermediate-Filament-associate Protein 
GAA    Gene Array Analyzer 
Gapdh    glyceraldehyde-3-phosphate dehydrogenase 
GATA4   protein binding the GATA DNA region 
GEO    Gene Expression Omnibus 
GFP    green fluorescence protein 
GLUT-1   glucose transporter 1 
H2O    water  
HAND1   Heart- and neural crest derivatives-expressed protein 1 
hBMP    human bone morphogenetic proteins 
HCl    hydrocloric acid 
HEB    helix-loop-helix protein bindinf to E2A and ITF2 proteins 
Hes1 /3    Hairy and enhancer of split 1/3  
Hey2 Hairy/enhancer-of-split related with YRPW motif protein 2, also 
known as cardiovascular helix-loop-helix factor 1 (CHF1) 
 
HGF    hepatocyte growth factor 
HIF-1b    hypoxia inducible factor 
HRP    horseradish peroxidase 
HSCs    hematopoietic stem cells 
HSPs    hot shock proteins  
IL6    interleuchin 6 
Il6st    Interleuchin 6 signal transducer or, gp130, or oncostatin M receptor 
Ilr1    IAA-amino acid hydrolase 
iPSs    induced pluripotent stem cells 
Itgα1    Integrin alpha 1 
IU    international unit 
KCl    potassium chloride 
KH2PO4   potassium dihydrogen phosphate 
KHCO3   potassium bicarbonate 
Kit    c-kit, CD117, belly spot, steel factor receptor 
KRTL-14   keratin 14 
LacZ    betagalactosidase gene 
LAD    left anterior descending coronary arteries 
LC1 Luciferase (luc) and the CRE recombinase (cre) gene under the 
control of a bidirectional minimal promoter (Ptetbi-1) 
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LIF    leukemia inhibitor factor 
Lin28a microRNA-binding protein binding the IGF-2 (insulin-like growth 
factor 2 
 
Lmna    Lamin A/C 
LoxP    lox sequences derived from bacteriophage P1 
Ly6    lymphocyte activation protein 6 
mCFP    mouse cyan fluorescence protein 
Mclust    model-based clustering 
MDSCs:   muscle derived stem cells 
Mdx    X chromosome-linked muscular dystrophy 
MEF    murine embryonic fibroblast 
Mef2c    Myocyte-specific enhancer factor 2C 
MeV    MultiExperiment Viewer 
mg    milligram 
MgSO4    magnesium sulfate 
MI    myocardial infarction 
ml    milliliter 
mm    millimeter 
mM    milliMolar 
MNF    myocyte nuclear factor 
MRF4    myogenic factor 6 (herculin) 
mRNA    messenger Ribonucleic acid 
MSCs    Mesenchymal Stem Cells 
Myf5    myogenic factor 5 
MyoD    myogenic differentiation 1 
Na2HPO4   Disodium hydrogen phosphate or sodium phosphate dibasic 
NaCl    sodium chloride 
NaHCO3   sodium bicarbonate 
Nanog    homeobox Transcription Factor Nanog 
NBT    nitroblue tetrazolium  
nCardio   murine neonatal cardiomyocytes 
ncRNA    non coding RNA 
nGFP    nuclear green fluorescence protein 
Nkx2.5 Cardiac-Specific Homeo Box NK2 Transcription Factor Related, 
Locus 5 
 
NTMT Alkaline phosphatase buffer (5 M NaCl, 1 M Tris-Cl (pH 9.5), 1 M 
MgCl2, Tween 20) 
 
Numbl    Numb-like 
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OCT    Optimum Cutting Temperature 
Oct-4    Octamer binding protein 4 
OrO    Oil red O 
P(14/17/21)   14/17/21 post natal days 
P/S    Penicillin/Streptomycin 
P4hb    Prolyl4-hydroxylase 
PAM    Partitioning Around Medoids 
Pax7    paired box transcription factor 7 
PBS    Phosphate Buffered Saline 
PCR    Polymerase Chain Reaction 
Pdgfalpha/beta  Platelet-derived growth factor subunit alpha/beta 
Pdgfralpha/beta  Platelet-derived growth factor receptor alpha/ beta 
PE    phycoerythrin 
PFA    Paraformaldehyde 
PGC1alpha/beta Peroxisome proliferator-activated receptor gamma coactivator 1-
alpha/beta 
 
PICs    progenitor interstitial cells 
PLAP    alkaline phosphatase placental 
PPRgamma   peroxisome proliferator-activated receptors 
PRDM16   PR domain containing 16 
Pref-1    Preadipocyte factor 1 
pTet    tetracycline promoter 
PW1/PEG3   Paternally express 3 
R26R    Rosa26 locus 
REX1    or ZFP42, acidic zinc finger protein 
RFP    red fluorescence protein 
RMA    Multi-Array Average 
RNA    Ribonucleic acid 
rpm    rounds per minutes 
RT-PCR   Real Time Polymerase Chain Reaction 
Sca1    Stem Cell Antigen 1 
SEM    Standard Error of the Mean 
SER    Smooth Endoplasmic Reticulum 
Sirt7    Sirtuin 7 
SM/C-2.6   monoclonal antibody specific for satellite cells 
SMAD1   Mothers against decapentaplegic homolog 1 
SOM    Self-Organizing Maps 
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SOTA    Self-Organizing Tree Algorithm 
SOX2    SRY, sex determining region Y-box 2  
SSC    Saline Sodium-Citrate Buffer 
SSEA1/3/4   Stage Specific Embryonic Antigens1/4  
STA-RT   Reverse Transcription (RT)-Specific Target Amplification (STA) 
Stat2/5a/6   Signal transducer and activator of transcription 2/5a/6 
SYBR green  N',N'-dimethyl-N-[4-[(E)-(3-methyl-1,3-benzothiazol-2-
ylidene)methyl]-1-phenylquinolin-1-ium-2-yl]-N-propylpropane-1,3-
diamine T: timine 
 
TA    transit amplifying 
TAC    transverse aortic constriction 
TAL    tibialis anterior left 
TAR    tibialis anterior right 
Tbx5    T-box transcription factor 5 
TerR    tetracycline repressor 
TERT    telomerase reverse transcriptase 
TetO    tetracycline operator 
Tgfb3    Transforming growth factor beta-3 
Tra-1-60/Tra-1-81  Tumor rejection antigen 1-60/1-81 
TRE    Tetracycline Response Element 
TRF-1/-2   Telomeric Repeat-Binding Factor 1/2 
Tris-HCl   tris(hydroxymethyl)aminomethane-hydrocloric acid 
TRITC    tetramethylrhodamine isothiocyanate 
TRIzol    TRIzol® Invitrogen Life Technologies 
tTA    tetracycline transactivator protein 
Ucp1    uncoupling protein 1 
UV    ultra violet 
v/v    volume/ volume 
Vegfc    Vascular endothelial growth factor C  
VP16 or Herpes simplex virus protein vmw65 or α-TIF (Trans Inducing 
Factor 
 
vs    versus 
YFP    yellow fluorescence protein 
Z/AP    LacZ/ Alkaline Phosphatase 
Z/EG    LacZ/enhanced green fluorescence protein 
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